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Heather A. Piwowar, PhD 
University of Pittsburgh, 2010 
 
Many initiatives encourage research investigators to share their raw research datasets 
in hopes of increasing research efficiency and quality. Despite these investments of 
time and money, we do not have a firm grasp on the prevalence or patterns of data 
sharing and reuse.  Previous survey methods for understanding data sharing patterns 
provide insight into investigator attitudes, but do not facilitate direct measurement of 
data sharing behaviour or its correlates.  In this study, we evaluate and use bibliometric 
methods to understand the impact, prevalence, and patterns with which investigators 
publicly share their raw gene expression microarray datasets after study publication. 
To begin, we analyzed the citation history of 85 clinical trials published between 
1999 and 2003.  Almost half of the trials had shared their microarray data publicly on 
the internet.  Publicly available data was significantly (p=0.006) associated with a 69% 
increase in citations, independently of journal impact factor, date of publication, and 
author country of origin. 
Digging deeper into data sharing patterns required methods for automatically 
identifying data creation and data sharing. We derived a full-text query to identify 
studies that generated gene expression microarray data.  Issuing the query in PubMed 
Central®, Highwire Press, and Google Scholar found 56% of the data-creation studies 
in our gold standard, with 90% precision.  Next, we established that searching 
ArrayExpress and the Gene Expression Omnibus databases for PubMed® article 
identifiers retrieved 77% of associated publicly-accessible datasets. 
We used these methods to identify 11603 publications that created gene 
expression microarray data.  Authors of at least 25% of these publications deposited 
their data in the predominant public databases.  We collected a wide set of variables 
about these studies and derived 15 factors that describe their authorship, funding, 
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institution, publication, and domain environments. In second-order analysis, authors 
with a history of sharing and reusing shared gene expression microarray data were 
most likely to share their data, and those studying human subjects and cancer were 
least likely to share. 
We hope these methods and results will contribute to a deeper understanding of 
data sharing behavior and eventually more effective data sharing initiatives. 
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1.0  INTRODUCTION 
Many initiatives encourage research data sharing in hopes of increasing research 
efficiency and quality, but the effectiveness of these early initiatives is not well 
understood.  Sharing and reusing scientific datasets have many potential benefits: in 
addition providing detail for original analyses, raw data can be used to explore related or 
new hypotheses, particularly when combined with other publicly available data sets. 
Real data is indispensable when investigating and developing study methods, analysis 
techniques, and software implementations. The larger scientific community also 
benefits: sharing data encourages multiple perspectives, helps to identify errors, 
discourages fraud, is useful for training new researchers, and increases efficient use of 
funding and patient population resources by avoiding duplicate data collection.   
Eager to encourage the realization of such benefits, funders, publishers, 
societies, and individual research groups have developed tools, resources, and policies 
to encourage investigators to make their data publicly available.  Despite these 
investments of time and money, we do not yet understand the rewards, prevalence or 
patterns of data sharing and reuse, the effectiveness of initiatives, or the costs, benefits, 
and impact of repurposing biomedical research data. 
Studies examining current data sharing behavior would be useful in three ways.  
First, an estimate of the prevalence with which data is shared, either voluntarily or under 
mandate, would provide a valuable baseline for assessing future adoption and 
continued intervention.  Second, analyses of current behavior will likely identify subfields 
(perhaps research areas with a particular disease or organism focus, or those in well 
funded research groups) with relatively high prevalence of data sharing; digging into 
these can illuminate valuable best practices.  Third, the same analyses will likely reveal 
subareas in which researchers rarely share their research datasets.  Future research 
could focus on these challenging areas, to understand their unique obstacles for data 
sharing and refine future initiatives accordingly.  You can not manage what you do not 
measure: understanding the rewards, prevalence, and patterns of data sharing and 
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withholding will facilitate effective refinement of data sharing initiatives to better address 
real-world needs.   
1.1 BACKGROUND 
Widespread adoption of the Internet now allows research results to be shared more 
readily than ever before.  This is true not only for published research reports, but also 
for the raw research data points that underlie the reports.  Investigators who collect and 
analyze data can submit their datasets to online databases, post them on websites, and 
include them as electronic supplemental information – thereby making the data easy to 
examine and reuse by other researchers. 
Reusing research data has many benefits for the scientific community.  New 
research hypotheses can be tested more quickly and inexpensively when duplicate data 
collection is reduced.  Data can be aggregated to study otherwise-intractable issues, 
and a more diverse set of scientists can become involved when analysis is opened 
beyond those who collected the original data.  Ethically, it has long been considered a 
tenet of scientific behavior to share results [1], thereby allowing close examination of 
research conclusions and facilitating others to build directly on previous work.  The 
ethical position is even stronger when the research has been funded by public money 
[2], or the data are donated by patients and so should be used to advance science by 
the greatest extent permitted by the donors [3]. 
However, whereas the general research community benefits from shared data, 
much of the burden for sharing the data falls to the study investigator.  A major cost is 
time: the data have to be formatted, documented, and released. Further, it is sometimes 
complicated to decide where to best publish data, since supplementary information and 
laboratory sites are transient [4-6]. Beyond a time investment, releasing data can induce 
fear. There is a possibility that the original conclusions may be challenged by a re-
analysis, whether due to possible errors in the original study [7], a misunderstanding or 
misinterpretation of the data [8], or simply more refined analysis methods. Future data 
miners might discover additional relationships in the data, some of which could disrupt 
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the planned research agenda of the original investigators. Investigators may fear they 
will be deluged with requests for assistance, or need to spend time reviewing and 
possibly rebutting future re-analyses. They might feel that sharing data decreases their 
own competitive advantage, whether future publishing opportunities, information trade-
in-kind offers with other labs, or potentially profit-making intellectual property. Finally, it 
can be complicated to release data. If not well-managed, data can become disorganized 
and lost. Some informed consent agreements may not obviously cover subsequent 
uses of data. De-identification can be complex. Study sponsors, particularly from 
industry, may not agree to release raw detailed information. Data sources may be 
copyrighted such that the data subsets cannot be freely shared. 
Recognizing that these disincentives make the establishment of a voluntary data 
sharing culture unlikely without policy guidance, many initiatives actively encourage or 
require that investigators make their raw data available for other researchers.  There is 
a well known adage inspired by William Thomson (Lord Kelvin) [9]: you cannot manage 
what you do not measure. For those with a goal of promoting responsible data sharing, 
it would be helpful to evaluate the effectiveness of requirements, recommendations, and 
tools. When data sharing is voluntary, insights could be gained by learning which 
datasets are shared, on what topics, by whom, and in what locations. When policies 
make data sharing mandatory, monitoring is useful to understand compliance and 
unexpected consequences. 
Unfortunately, it is difficult to monitor data sharing because data can be shared in 
so many different ways.  Previous assessments of data sharing have included manual 
curation [10-12] and investigator self-reporting [13].  These methods are only able to 
identify instances of data sharing and data withholding in a limited number of cases, and 
therefore are unable to support widespread inquiry into patterns of data sharing 
behavior.  We hope this project supplements previous research to address these 
limitations. 
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1.1.1 The potential benefits of data sharing 
Sharing information facilitates science. Reusing previously-collected data in new studies 
allows these valuable resources to contribute far beyond their original analysis [14].  In 
addition to being used to confirm original results, raw data can be used to explore 
related or new hypotheses, particularly when combined with other publicly available 
data sets. Real data is indispensable when investigating and developing study methods, 
analysis techniques, and software implementations. The larger scientific community 
also benefits: sharing data encourages multiple perspectives, helps to identify errors, 
discourages fraud, is useful for training new researchers, and increases efficient use of 
funding and patient population resources by avoiding duplicate data collection. 
Believing that that these benefits outweigh the costs of sharing research data, 
many initiatives actively encourage investigators to make their data available. Some 
journals require the submission of detailed biomedical data to publicly available 
databases as a condition of publication [15, 16]. Since 2003, the NIH has required a 
data sharing plan for all large funding grants and has more recently introduced stronger 
requirements for genome-wide association studies [17, 18]; other funders have similar 
policies.  Several government whitepapers [14, 19] and high-profile editorials [19-25] 
call for responsible data sharing and reuse, large-scale collaborative science is 
providing the opportunity to share datasets within and outside of the original research 
projects [20, 21], and tools, standards, and databases are developed and maintained to 
facilitate data sharing and reuse.   
1.1.2 Current data sharing practice:  forces in support 
As highlighted above, sharing research data has many potential benefits to society. 
Although sharing of data has always been an aspiration of the scientific enterprise, it 
has only been common in a few subdisciplines.  Forces are now converging to make it 
an achievable and everyday practice.  
Datasets are larger than they have ever been – and larger than any single team 
of scientists can analyze exhaustively. The ubiquitous sharing and reuse of DNA 
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sequences in Genbank® has clearly demonstrated the power of openly shared data. 
Other high-throughput hypothesis-generating datasets, such as genome-wide 
association studies [17, 22], gene expression microarrays [23], proteomics mass 
spectra [24], and brain images [25] allow data to be repurposed to answer multiple 
research questions. Extensive datasets are also generated within the clinical setting, 
particularly through the adoption of electronic health records. Stakeholders have begun 
to develop recommendations and guidelines for the complex ethical, legal, and technical 
issues surrounding the reuse and sharing of health data beyond primary healthcare 
[26]. 
Research is increasingly performed within networks of multi-disciplinary teams. 
The NIH Roadmap [27] and other initiatives [21, 28-30] have recognized that significant 
scientific progress requires collaboration. Collaborations develop and adopt 
frameworks, standards, tools, and policies to share data among investigators. This work 
can facilitate sharing their data beyond the boundaries of the original research partners. 
Today’s collaborative science on large datasets is performed within an extremely 
tight biomedical funding environment. Many funding agencies have instituted data-
sharing policies [31], hoping to accelerate scientific progress while avoiding the cost of 
duplicative collection efforts. The NIH Data Sharing Policy, adopted in 2003, requires a 
data sharing plan for all research grants over $500K [17].   The NIH stipulates additional 
requirements for specific domains. For example, all funded genome-wide association 
studies (GWAS) are now expected to share their data in the centralized NCBI database, 
dbGaP [18, 22]. Complementing and extending these funding agency requirements, 
many biomedical journals require or recommend that data be shared as a condition of 
publication [15, 16, 19].  Some journals delineate the responsibilities in detail and 
include procedures for addressing data sharing noncompliance [16, 33]. 
Open, centralized databases such as Genbank, Uniprot, and the Gene 
Expression Omnibus have evolved into de facto homes for specific types of data [34]. 
Standards for minimum data inclusion and data formats have been developed for many 
types of datasets. The challenge of integrating datasets has spurred research progress 
on ontologies and semantic description methods. Projects such as NCBI’s Entrez 
database suite [35], the Semantic Web for Life Sciences [36], the National Center for 
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Biomedical Ontology’s Bioportal framework [37], and caBIG [29, 38, 39] provide visions 
for the future of research when data is more universally available and interoperable. 
Data sharing and integration are being actively pursued outside of biomedical 
research, in other scientific fields (physics, astronomy, environmental science) and also 
by the general public [40]. Several websites encourage uploading and visualizing all 
sorts of data: the “Tasty Data Goodies” at Swivel (http://www.swivel.com) and IBM’s 
Many Eyes (http://www.many-eyes.com) are popular examples. Widespread adoption of 
Web 2.0 technologies, including blogging, tagging, wikis, and mashups, suggest that 
our next generation of scientists will expect and embrace a world of research remixes 
[40]. 
Finally, I note the complementary forces of open access and pre-print 
publications, open notebook science projects [41], open source code [42], Creative 
Commons copyright licenses (http://creativecommons.org/) for many kinds of original 
content (including data), and two recent public access policies. The NIH Public Access 
Policy requires all NIH-funded investigators to submit their peer-reviewed manuscripts 
to PubMed Central to ensure public access, as of April 2008 [43]. In February 2008, the 
faculty of Harvard University voted to make all faculty scholarly publications freely 
available in an online open-access repository [44], the first such resolution by a 
university in the United States. While these policies do not apply to data beyond that 
provided within the manuscripts, they clearly demonstrate a political will to support 
sharing research results “to help advance science and improve human health” 
(http://publicaccess.nih.gov) and “promote free and open access to significant, ongoing 
research” [44]. 
1.1.3 Current data sharing practice:  forces in opposition 
While many forces are converging to enhance our ability to share data, there are 
significant social, organizational, technical and legislative factors that may impede them.  
Investigators may restrict access to data to maximize the professional and 
economic benefit that they accrue from data they generate, even though they also gain 
advantage by accessing data produced by others.  
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A review of genomic data sharing highlighted the complexity of stakeholder 
interests both for and against data sharing [45], beyond those of the original 
investigators.  Study subjects may have personal interests in privacy and confidentiality 
that exceed their personal interests in contributing to new methods of detecting and 
treating disease. Academic health centers may view data sharing as a threat to 
intellectual property, with the potential to impede spin-offs and start-ups that bring 
revenue and act as incubators for future research. Industrial sponsorship may hinder 
plans for sharing data. Changes in the regulatory environment make the sharing of data 
more complex, and may necessitate more stringent oversight to ensure compliance and 
minimize risk. Finally, limitations imposed by specific technologies undermine the ability 
of a uniform approach to generalize across different data types and regulatory 
requirements.  
It is often difficult to effectively incent and mandate data sharing.  Mandates are 
often controversial [46-48] while requests and unenforced mandates are often ignored 
[49].  The effect of funder policies like the NIH Data Sharing Policy have not been 
systematically studied, but anecdotal evidence suggests that many researchers view 
funder policies as optional, since they data sharing plans are not considered as part of 
scientific evaluation and there are no penalties for noncompliance [50]. 
I believe that a critical element in balancing these opposing forces is a better 
understanding of current data sharing behavior, patterns, and predictors to be used for 
communicating and refining sharing best-practices. 
 
1.2 PREVIOUS RESEARCH ON DATA SHARING BEHAVIOR 
A few investigations into data sharing behavior and attitudes have initiated work in this 
area.  Findings and outstanding challenges are highlighted below. 
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1.2.1 Measuring and modeling data sharing behavior 
Most measurements of data sharing prevalence have manually searched for shared 
datasets across a subset of journals [10, 11, 49], or systematically contacted authors to 
ask for shared datasets [51].  These studies have found that data sharing levels are 
high (but less than 100%) in a few cases, but overall prevalence is low.  For example, 
Ochsner et al. [10] found that despite the maturity of gene expression microarray data 
sharing infrastructure and multitude of funder and journal mandates, overall rates of 
sharing gene expression microarray data online is about 50%. 
These analyses have not correlated their prevalence findings with other variables 
to detect patterns.  Multivariate analyses have relied upon surveyed attitudes and 
intentions (described below), rather than measured characteristics.  
1.2.2 Measuring and modeling data sharing attitudes and intentions 
The largest body of knowledge about motivations and predictors for biomedical data 
sharing and withholding comes from Campbell and co-authors. They surveyed 
researchers, asking whether they have ever requested data and been denied, or 
themselves denied other researchers from access to data. Results indicated that 
participation in relationships with industry, mentors’ discouragement of data sharing, 
negative past experience with data sharing, and male gender were associated with data 
withholding [13]. In another survey, among geneticists who said they intentionally 
withheld data related to their published work, 80% said it was too much effort to share 
the data, 64% said they withheld data to protect the ability of a junior team member to 
publish, and 53% withheld data to protect their own publishing opportunities [52]. 
Occasionally, the administrators of centralized data servers publish feedback 
surveys of their users. As an example, Ventura reports a survey of researchers who 
submitted and reviewed microarray studies in the Physiological Genomics journal after 
its mandatory data submission policy had been in place for two years. Almost all (92%) 
authors said that they believed depositing microarray data was of value to the scientific 
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community and about half (55%) were aware of other researchers reusing data from the 
database [53]. 
In related research, the information science and management of information 
systems communities have developed several models of knowledge sharing.  These 
models often use either case studies [54] or opinions and attitudes gathered through 
validated survey instruments ([44, 55-57], and many more).  Studied domains include 
knowledge sharing within an organization, volunteering knowledge in open social 
networks, physician knowledge sharing in hospitals, participation in open source 
projects, academic contributions to institutional archives, and other related activities. 
1.2.3 Identifying instances of data sharing 
While surveys have provided insight into sharing and reuse behavior, other issues are 
best examined by studying the demonstrated behavior of scientists. Unfortunately, 
observed measurement of data behavior is difficult because of the complexity in 
identifying all episodes of data sharing and reuse. Although indications of sharing and 
reuse usually exist within a published research report, the descriptions are in 
unstructured free text and thus complex to extract. 
Most studies of data sharing to date have used a manual review to identify 
shared datasets (e.g. [10, 11, 49]). 
One automated approach for identifying data sharing behavior is to follow the 
“primary citation” field of database submission entries.  Unfortunately, this is imperfect, 
since these references often missing when data is submitted prior to study publication. 
Populating the submission citation fields retrospectively requires intensive manual effort, 
as demonstrated by the recent Protein Data Bank remediation project [57, 58], and thus 
is not usually performed. No effective way exists to automatically retrieve and index 
data housed on personal or lab websites or journal supplementary information. 
Related research has examined the degree to which data remains available after 
it has been shared. Multiple studies underscore the transience of supplementary 
information [5], website URLs [6], and corresponding author email addresses [44]. 
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1.2.4 Evaluating the impact of data sharing policies 
Despite many funder and journal policies requesting and requiring data sharing, the 
impact of these policies have only been measured in small and disparate studies. 
McCain manually categorized the journal “Instruction to Author” statements in 1995 [15]. 
A more recent manual review of gene sequence papers found that, despite 
requirements, up to 15% of articles did not submit their datasets to Genbank [11].  
Analyses of reproducibility in the political science literature suggests that only actively 
enforced journal policies are effective [49]. 
Studying the impact of data sharing policies is difficult because policies are often 
confounded with other variables. If, for example, impact factor is positively correlated 
with a strong journal data sharing policy as well as a large research impact, it is difficult 
to distinguish the direction of causation. Evaluating data sharing policies would ideally 
involve a randomized controlled trial, but unfortunately this is impractical. 
In related work, evaluations have been done to estimate the impact of reporting 
guidelines [59].  
1.2.5 Estimating the costs and benefits of data sharing 
Estimating the costs and benefits of data sharing would be challenging even with a 
comprehensive dataset of occurrences. A complete evaluation would require comparing 
projects that shared with other similar projects that did not, across a wide variety of 
variables including person-hours-till-completion, total project cost, received citations and 
their impact, the number and impact of future publications, promotion, success in future 
grant proposals, and general recognition and respect in the field. 
Pienta [60] is currently investigating these questions with respect to social 
science research data and publications. Zimmerman [61] has studied the ways in which 
ecologists find and validate datasets to overcome the personal costs and risks of data 
reuse. 
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Examining variables for their benefits on research impact is a common theme 
within the field of bibliometrics. Research impact is usually approximated by citation 
metrics, despite their recognized limitations. 
1.2.6 Related research fields 
Evaluation of data sharing and reuse behavior is related to a number of other active 
research fields: code reusability in software engineering, motivation in open source 
projects, online knowledge sharing communities, and corporate knowledge sharing, 
tools for collaboration, evaluating research output, the sociological study of altruism, 
information retrieval, usage metrics, data standards, the semantic web, open access, 
and open notebook science. 
 
1.3 RESEARCH DESIGN AND METHODS 
The long-term goal of this research is to accelerate research progress by increasing 
effective data reuse through informed improvement of data sharing and reuse tools and 
policies. The objective of this research project is to examine the feasibility of evaluating 
data sharing behavior based on examination of the biomedical literature.  
This research addressed the following specific aims: 
1.3.1 Aim 1: Does sharing have benefit for those who share? 
I investigated the association between sharing raw microarray data and subsequent 
citation rate of published studies.  I used datasets generated by a small, relatively 
homogeneous set of cancer gene expression microarray clinical trials.  Multivariate 
analysis was used to statistically controlling for potential confounders.  The results of 
Aim 1 provided motivation for Aim 2 and preliminary work for Aim 3.  
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1.3.2 Aim 2: Can sharing and withholding be systematically measured?  
Because the manual methods used to conduct Aim 1 did not scale to larger analyses, I 
investigated automatic methods for measuring data sharing and withholding behavior.  
First, articles that generated gene expression microarray data were identified using NLP 
on full-text research.  Second, to assess whether the authors of these data-generating 
studies shared or withheld their data, I investigated using database submission citation 
links as evidence of data sharing.  The results of Aim 2 were used to generate a dataset 
for Aim 3. 
1.3.3 Aim 3: How often is data shared?  What predicts sharing?  How can we 
model sharing behavior? 
First, I applied the classification systems described in Aim 2 to a wide spectrum of the 
biomedical literature to identify articles that generated gene expression microarray data 
and, subsequently, which of the articles that generated data also shared it.  Then, for 
each of the articles, I collected and analyzed features related to the authors, their 
institutional and funding environment, the study itself, and the publishing mechanism.  I 
used univariate and multivariate statistics to investigate which of these features are 
associated with dataset sharing.  Finally, I used exploratory factor analysis to derive a 
model that could be used to explain data sharing decisions based on my measured 
variables. 
1.4 RELATED RESEARCH APPLICATIONS OF METHODS 
1.4.1 Citation analysis for adoption and impact of open science 
Citation analysis has been used to assess several aspects of the adoption and impact 
of open science, particularly literature open access.  Eysenbach [62] found that authors 
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who chose to make their articles open access in the Proceedings of the National 
Academy of Sciences received more citations within the first year after publication, 
Wren [63] correlated journal impact factor with the adoption rate of author-shared 
reprints, and many others.  Other research have used citations to see how scientists 
use each other’s work [64] and the relative impact of various study designs [65]. 
Many authors study factors that underlie citation rate; these highlight important 
factors to include as potential confounders whenever a detailed citation analysis of a 
new variable [66, 67].  Ongoing research attempts to identify the best way to represent 
various issues such as author ambiguity [68], author productivity [69, 70], institutional 
environment [71], journal impact factor [72-76] and clean and comprehensive citation 
data [77]. 
Finally, several researchers have proposed methods for citations of data to make 
studying the issue of reuse easier in the long run, such as [43] and [78], and examined 
the extent to which citations are an accurate proxy for peer ratings of quality [79]. 
1.4.2 Natural language processing of the biomedical literature 
Natural language processing of the biomedical literature is traditionally organized into 
information retrieval, entity recognition, information extraction, hypothesis generation, 
and heterogeneous integration [80].  Most work has been on abstracts, because they 
are free, easy to obtain, and in a standardized format from MEDLINE®.  Unfortunately, 
a great deal of information resides only in article full text. The TREC Genomics 
2006/2007 tasks opened up a selection of free text for Information Retrieval research, 
and the Open Access subset at PubMed Central is another homogeneous, free, easy 
subset to obtain.  Consequently, more research is beginning to focus on full-text [81]. 
Most research has focused on the needs of biologists or curators [82], but 
starting to be some investigations into automated techniques to help find articles for 
review based on the text [91-94], identification of the relationships between citing and 
cited articles [83, 84], and analysis of the methods section to enumerate the diversity of 
wet lab method use [85]. 
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Techniques vary depending on the task, but stemming, synonyms, and n-grams 
are a mainstay [86].   Query expansion to include all query aspects have also been 
shown to help [87].  The availability of full text articles in PMC, Google Scholar, and 
other portals is spurring new approaches [88].  
Finally, NLP techniques applied to clinical text might be of informative.  For 
example, Melton et al. [89] also faces the issue of identifying records based on snippets 
of full text, though in their case it is adverse reactions in clinical discharge summaries. 
1.4.3 Regression and factor analysis for deriving and evaluating models of 
sharing behavior 
Most models of sharing behavior are based on established surveys, and thus evaluate 
their models using confirmatory analysis [101-105].  However, a few research projects 
instead use linear regression, such as [13, 56, 90-92].  Siemsen et al. [93] compare a 
regression model to that derived from constraining factor analysis.  Finally, several 
studies involve exploratory factor analysis [71, 94, 95]. 
1.5 OUTLINE OF THE DISSERTATION 
This chapter has provided an introduction to the dissertation and its topic.  Each aim is 
described separately as a self-contained research report including an introduction, 
methods, results, and discussion.  Aim 1 is covered in Chapter 2, Aim 2 in Chapters 3 
and 4, and Aim 3 in Chapter 5.  An overall discussion of contributions, implications, and 
future work is provided in the final chapter. 
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2.0  AIM 1:  SHARING DETAILED RESEARCH DATA IS ASSOCIATED WITH 
INCREASED CITATION RATE 
Background 
Sharing research data provides benefit to the general scientific community, but the 
benefit is less obvious for the investigator who makes his or her data available. 
Principal Findings 
We examined the citation history of 85 cancer microarray clinical trial publications with 
respect to the availability of their data. The 48% of trials with publicly available 
microarray data received 85% of the aggregate citations. Publicly available data was 
significantly (p = 0.006) associated with a 69% increase in citations, independently of 
journal impact factor, date of publication, and author country of origin using linear 
regression. 
Significance 
This correlation between publicly available data and increased literature impact may 
further motivate investigators to share their detailed research data. 
2.1 INTRODUCTION 
Sharing information facilitates science. Publicly sharing detailed research data–sample 
attributes, clinical factors, patient outcomes, DNA sequences, raw mRNA microarray 
measurements–with other researchers allows these valuable resources to contribute far 
beyond their original analysis [14]. In addition to being used to confirm original results, 
raw data can be used to explore related or new hypotheses, particularly when combined 
with other publicly available data sets. Real data is indispensable when investigating 
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and developing study methods, analysis techniques, and software implementations. The 
larger scientific community also benefits: sharing data encourages multiple 
perspectives, helps to identify errors, discourages fraud, is useful for training new 
researchers, and increases efficient use of funding and patient population resources by 
avoiding duplicate data collection. 
Believing that that these benefits outweigh the costs of sharing research data, 
many initiatives actively encourage investigators to make their data available. Some 
journals, including the PLoS family, require the submission of detailed biomedical data 
to publicly available databases as a condition of publication [15, 96, 97]. Since 2003, the 
NIH has required a data sharing plan for all large funding grants. The growing open-
access publishing movement will perhaps increase peer pressure to share data. 
However, while the general research community benefits from shared data, much 
of the burden for sharing the data falls to the study investigator. Are there benefits for 
the investigators themselves? 
A currency of value to many investigators is the number of times their 
publications are cited. Although limited as a proxy for the scientific contribution of a 
paper [98], citation counts are often used in research funding and promotion decisions 
and have even been assigned a salary-increase dollar value [99]. Boosting citation rate 
is thus is a potentially important motivator for publication authors. 
In this study, we explored the relationship between the citation rate of a 
publication and whether its data was made publicly available. Using cancer microarray 
clinical trials, we addressed the following questions: Do trials which share their 
microarray data receive more citations? Is this true even within lower profile trials? What 
other data-sharing variables are associated with an increased citation rate? While this 
study is not able to investigate causation, quantifying associations is a valuable first 
step in understanding these relationships. Clinical microarray data provides a useful 
environment for the investigation: despite being valuable for reuse and extremely costly 
to collect, is not yet universally shared. 
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2.2 MATERIALS AND METHODS 
2.2.1 Identification and Eligibility of Relevant Studies 
We compared the citation impact of clinical trials which made their cancer microarray 
data publicly available to the citation impact of trials which did not. A systematic review 
by Ntzani and Ioannidis [100] identified clinical trials published between January 1999 
and April 2003 which investigated correlations between microarray gene expression and 
human cancer outcomes and correlates. We adopted this set of 85 trials as the cohort 
of interest. 
2.2.2 Data Extraction 
We assessed whether each of these trials made its microarray data publicly available by 
examining a variety of publication and internet resources. Specifically, we looked for 
mention of Supplementary Information within the trial publication, searched the Stanford 
Microarray Database (SMD) [101], Gene Expression Omnibus (GEO) [102], 
ArrayExpress [103], CIBEX [104], and the NCI GeneExpression Data Portal 
(GEDP)(gedp.nci.nih.gov), investigated whether a data link was provided within 
Oncomine [105], and consulted the bibliography of data re-analyses. Microarray data 
release was not required by any journals within the timeframe of these trial publications. 
Some studies may make their data available upon individual request, but this adds a 
burden to the data user and so was not considered “publicly available” for the purposes 
of this study. 
We attempted to determine the date data was made available through notations 
in the published paper itself and records within the WayBackMachine internet archive 
(www.archive.org/web/web.php). Inclusion in the WayBackMachine archive for a given 
date proves a resource was available, however, because archiving is not 
comprehensive, absence from the archive does not itself demonstrate a resource did 
not exist on that date. 
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The citation history for each trial was collected through the Thomson Scientific 
Institute for Scientific Information (ISI) Science Citation Index at the Web of Science 
Database (www.isinet.com). Only citations with a document type of ‘Article’ were 
considered, thus excluding citations by reviews, editorials, and other non-primary 
research papers. 
For each trial, we also extracted the impact factor of the publishing journal (ISI 
Journal Citation Reports 2004), the date of publication, and the address of the authors 
from the ISI Web of Science. Trial size, clinical endpoint, and microarray platform were 
extracted from the Ntzani and Ioannidis review [100]. 
2.2.3 Analysis 
The main analyses addressed the number of citations each trial received between 
January 2004 and December 2005. Because the pattern of citations rates is complex–
changing not only with duration since publication but also with maturation of the general 
microarray field–a confirmatory analysis was performed using the number of citations 
each publication received within the first 24 months of its publication. 
Although citation patterns covering a broad scope of literature types are left-
skewed [106], we verified that citation rates within our relatively homogeneous cohort 
were roughly log-normal and thus used parametric statistics. 
Multivariate linear regression was used to evaluate the association between the 
public availability of a trial's microarray data and number of citations (after log 
transformation) it received. The impact factor of the journal which published each trial, 
the date of publication, and the country of authors are known to correlate to citation rate 
[107], so these factors were included as covariates. Impact factor was log-transformed, 
date of publication was measured as months since January 1999, and author country 
was coded as 1 if any investigator has a US address and 0 otherwise. 
Since seminal papers–often those published early in the history a field or in very 
high-impact journals–receive an unusually high number of citations, we performed a 
subset analysis to determine whether our results held when considering only those trials 
which were published after 2000 and in lower-impact (<25) journals. 
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Finally, as exploratory analysis within the subset of all trials with publicly 
available microarray data, we looked at the linear regression relationships between 
additional covariates and citation count. Covariates included trial size, clinical endpoint, 
microarray platform, inclusion in various public databases, release of raw data, mention 
of supplementary information, and reference within the Oncomine [105] repository. 
Statistical analysis was performed using the stats package in R version 2.1 [108]. 
P-values are two-tailed. 
2.3 RESULTS 
We studied the citations of 85 cancer microarray clinical trials published between 
January 1999 and April 2003, as identified in a systematic review by Ntzani and 
Ioannidis [100] and listed in Supplementary Text S1. We found 41 of the 85 clinical trials 
(48%) made their microarray data publicly available on the internet. Most data sets were 
located on lab websites (28), with a few found on publisher websites (4), or within public 
databases (6 in the Stanford Microarray Database (SMD) [101], 6 in Gene Expression 
Omnibus (GEO) [102], 2 in ArrayExpress [103], 2 in the NCI GeneExpression Data 
Portal (GEDP) (gedp.nci.nih.gov); some datasets in more than one location). The 
internet locations of the datasets are listed in Supplementary Text S2. The majority of 
datasets were made available concurrently with the trial publication, as illustrated within 
the WayBackMachine internet archives (www.archive.org/web/web.php) for 25 of the 
datasets and mention of supplementary data within the trial publication itself for 10 of 
the remaining 16 datasets. As seen in Table 1, trials published in high impact journals, 
prior to 2001, or with US authors were more likely to share their data. 
 
 
Table 1:  Characteristics of eligible publications 
 
 
 
The cohort of 85 trials was cited an aggregate of 6239 times in 2004–2005 by 
3133 distinct articles (median of 1.0 cohort citation per article, range 1–23). The 48% of 
trials which shared their data received a total of 5334 citations (85% of aggregate), 
distributed as shown in Figure 1. 
 
 
Figure 1:  Distribution of 2004-2005 citation counts of 85 publications 
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Whether a trial's dataset was made publicly available was significantly associated 
with the log of its 2004–2005 citation rate (69% increase in citation count; 95% 
confidence interval: 18 to 143%, p=0.006), independent of journal impact factor, date of 
publication, and US authorship. Detailed results of this multivariate linear regression are 
given in Table 2. A similar result was found when we regressed on the number of 
citations each trial received during the 24 months after its publication (45% increase in 
citation count; 95% confidence interval: 1 to 109%, p = 0.050). 
 
 
Table 2:  Multivariate regression on citation count of 85 publications 
 
 
 
To confirm that these findings were not dependent on a few extremely high-
profile papers, we repeated our analysis on a subset of the cohort. We define papers 
published after the year 2000 in journals with an impact factor less than 25 as lower-
profile publications. Of the 70 trials in this subset, only 27 (39%) made their data 
available, although they received 1875 of 2761 (68%) aggregate citations. The 
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distribution of the citations by data availability in this subset is shown in Figure 2. The 
association between data sharing and citation rate remained significant in this lower-
profile subset, independent of other covariates within a multivariate linear regression 
(71% increase in citation count; 95% confidence interval: 19 to 146%, p = 0.005). 
 
 
 
Figure 2:  Distribution of 2004-2005 citation counts of 70 lower-profile publications 
 
 
Lastly, we performed exploratory analysis on citation rate within the subset of 
trials which shared their microarray data; results are given in Table 3. The number of 
patients in a trial and a clinical endpoint correlated with increased citation rate. 
Assuming shared data is actually re-analyzed, one might expect an increase in citations 
for those trials which generated data on a standard platform (Affymetrix), or released it 
in a central location or format (SMD, GEO, GEDP) [109]. However, the choice of 
platform was insignificant and only those trials located in SMD showed a weak trend of 
increased citations. In fact, the 6 trials with data in GEO (in addition to other locations 
for 4 of the 6) actually showed an inverse relationship to citation rate, though we 
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hesitate to read much into this due to the small number of trials in this set. The few trials 
in this cohort which, in addition to gene expression fold-change or other preprocessed 
information, shared their raw probe data or actual microarray images did not receive 
additional citations. Finally, although finding diverse microarray datasets online is non-
trivial, an additional increase in citations was not noted for trials which mentioned their 
Supplementary Material within their paper, nor for those trials with datasets identified by 
a centralized, established data mining website. In summary, only trial design features 
such as size and clinical endpoint showed a significant association with citation rate; 
covariates relating to the data collection and how the data was made available only 
showed very weak trends. Perhaps with a larger and more balanced sample of trials 
with shared data these trends would be more clear. 
 
 
Table 3:  Exploratory regression on citation count for 41 publications with shared data 
 
 
2.4 DISCUSSION 
We found that cancer clinical trials which share their microarray data were cited about 
70% more frequently than clinical trials which do not. This result held even for lower-
profile publications and thus is relevant to authors of all trials. 
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A parallel can be drawn between making study data publicly available and 
publishing a paper itself in an open-access journal. The association with an increased 
citation rate is similar [110]. While altruism no doubt plays a part in the motivation of 
authors in both cases, studies have found that an additional reason authors choose to 
publish in open-access journals is that they believe their articles will be cited more 
frequently [62, 111], endorsing the relevance of our result as a potential motivator. 
We note an important limitation of this study: the demonstrated association does 
not imply causation. Receiving many citations and sharing data may stem from a 
common cause rather than being directly causally related. For example, a large, high-
quality, clinically important trial would naturally receive many citations due to its medical 
relevance; meanwhile, its investigators may be more inclined to share its data than they 
would be for a smaller trial-perhaps due greater resources or confidence in the results. 
Nonetheless, if we speculate for a moment that some or all of the association is 
indeed causal, we can hypothesize several mechanisms by which making data 
available may increase citations. The simplest mechanism is due to increased 
exposure: listing the dataset in databases and on websites will increase the number of 
people who encounter the publication. These people may then subsequently cite it for 
any of the usual reasons one cites a paper, such as paying homage, providing 
background reading, or noting corroborating or disputing claims ([112] provides a 
summary of research into citation behavior). More interestingly, evidence suggests that 
shared microarray data is indeed often reanalyzed [53], so at least some of the 
additional citations are certainly in this context. Finally, these re-analyses may spur 
enthusiasm and synergy around a specific research question, indirectly focusing 
publications and increasing the citation rate of all participants. These hypotheses are 
not tested in this study: additional research is needed to study the context of these 
citations and the degree, variety, and impact of any data re-use. Further, it would be 
interesting to assess the impact of reuse on the community, quantifying whether it does 
in fact lead to collaboration, a reduction in resource use, and scientific advances. 
Since it is generally agreed that sharing data is of value to the scientific 
community [19, 53, 113-116], it is disappointing that less than half of the trials we looked 
at made their data publicly available. It is possible that attitudes may have changed in 
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the years since these trials were published, however even recent evidence (in a field 
tangential to microarray trials) demonstrates a lack of willingness and ability to share 
data: an analysis in 2005 by Kyzas et al. [117] found that primary investigators for 17 of 
63 studies on TP53 status in head and neck squamous cell carcinoma did not respond 
to a request for additional information, while 5 investigators replied they were unable to 
retrieve raw data. 
Indeed, there are many personal difficulties for those who undertake to share 
their data [14]. A major cost is time: the data have to be formatted, documented, and 
released. Unfortunately this investment is often larger than one might guess: in the 
realm of microarray and particularly clinical information, it is nontrivial to decide what 
data to release, how to de-identify it, how to format it, and how to document it. Further, it 
is sometimes complicated to decide where to best publish data, since supplementary 
information and laboratory sites are transient [4, 5]. Beyond a time investment, releasing 
data can induce fear. There is a possibility that the original conclusions may be 
challenged by a re-analysis, whether due to possible errors in the original study [118], a 
misunderstanding or misinterpretation of the data [8], or simply more refined analysis 
methods. Future data miners might discover additional relationships in the data, some 
of which could disrupt the planned research agenda of the original investigators. 
Investigators may fear they will be deluged with requests for assistance, or need to 
spend time reviewing and possibly rebutting future re-analyses. They might feel that 
sharing data decreases their own competitive advantage, whether future publishing 
opportunities, information trade-in-kind offers with other labs, or potentially profit-making 
intellectual property. Finally, it can be complicated to release data. If not well-managed, 
data can become disorganized and lost. Some informed consent agreements may not 
obviously cover subsequent uses of data. De-identification can be complex. Study 
sponsors, particularly from industry, may not agree to release raw detailed information. 
Data sources may be copyrighted such that the data subsets can not be freely shared, 
though it is always worth asking. 
Although several of these difficulties are challenging to overcome, many are 
being addressed by a variety of initiatives, thereby decreasing the barriers to data 
sharing. For example, within the area of microarray clinical trials, several public 
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microarray databases (SMD [119], GEO [102], ArrayExpress [103], CIBEX [104], 
GEDP(gedp.nci.nih.gov)) offer an obvious, centralized, free, and permanent data 
storage solution. Standards have been developed to specify minimal required data 
elements (MIAME [120] for microarray data, REMARK [121] for prognostic study 
details), consistent data encoding (MAGE-ML [122] for microarray data), and semantic 
models (BRIDG (www.bridgproject.org) for study protocol details). Software exists to 
help de-identify some types of patient records (De-ID [123]). The NIH and other 
agencies allow funds for data archiving and sharing. Finally, large initiatives (NCI's 
caBIG [39]) are underway to build tools and communities to enable and advance 
sharing data. 
Research consumes considerable resources from the public trust. As data 
sharing gets easier and benefits are demonstrated for the individual investigator, 
hopefully authors will become more apt to share their study data and thus maximize its 
usefulness to society. 
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3.0  AIM 2A:  USING OPEN ACCESS LITERATURE TO GUIDE FULL-TEXT 
QUERY FORMULATION  
Background 
Much scientific knowledge is contained in the details of the full-text biomedical 
literature.  Most research in automated retrieval presupposes that the target literature 
can be downloaded and preprocessed prior to query. Unfortunately, this is not a 
practical or maintainable option for most users due to licensing restrictions, website 
terms of use, and sheer volume.  Scientific article full-text is increasingly queryable 
through portals such as PubMed Central, Highwire Press, Scirus, and Google Scholar.  
However, because these portals only support very basic Boolean queries and full text is 
so expressive, formulating an effective query is a difficult task for users.  We propose 
improving the formulation of full-text queries by using the open access literature as a 
proxy for the literature to be searched.  We evaluated the feasibility of this approach by 
building a high-precision query for identifying studies that perform gene expression 
microarray experiments. 
Methodology and Results 
We built decision rules from unigram and bigram features of the open access literature.   
Minor syntax modifications were needed to translate the decision rules into the query 
languages of PubMed Central, Highwire Press, and Google Scholar.  We mapped all 
retrieval results to PubMed identifiers and considered our query results as the union of 
retrieved articles across all portals.  Compared to our reference standard, the derived 
full-text query found 56% (95% confidence interval, 52% to 61%) of intended studies, 
and 90% (86% to 93%) of studies identified by the full-text search met the reference 
standard criteria.  Due to this relatively high precision, the derived query was better 
suited to the intended application than alternative baseline MeSH® queries. 
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Significance 
Using open access literature to develop queries for full-text portals is an open, flexible, 
and effective method for retrieval of biomedical literature articles based on article full-
text.  We hope our approach will raise awareness of the constraints and opportunities in 
mainstream full-text information retrieval and provide a useful tool for today’s 
researchers. 
3.1 BACKGROUND 
Much scientific information is available only in the full body of a scientific article. Full-text 
biomedical articles contain unique and valuable information not encapsulated in titles, 
abstracts, or indexing terms.  Literature-based hypothesis generation, systematic 
reviews, and day-to-day literature surveys often require retrieving documents based on 
information in full-text only. 
Progress has been made in accurately retrieving documents and passages 
based on their full-text content. Research efforts, relying on advanced machine-learning 
techniques and features such as parts of speech, stemmed words, n-grams, semantic 
tags, and weighted tokens, have focused on situations in which complete full-text 
corpora are available for preprocessing.   Unfortunately, most users do not have an 
extensive, local, full-text library. Establishing and maintaining a machine-readable 
archive involves complex issues of permissions, licenses, storage, and formats.  
Consequently, applying cutting-edge full-text information retrieval and extraction 
research is not feasible for mainstream scientists. 
Several portals offer a simple alternative: PubMed Central, Highwire Press, 
Scirus, and Google Scholar provide full-text query interfaces to an increasingly large 
subset of the biomedical literature. Users can search for full-text keywords and phrases 
without maintaining a local archive; in fact, they need not have subscription nor access 
privileges for the articles they are querying.  Portals return a list of articles that match 
the query (often with a matching snippet).  Users can manually review this list and 
download articles subject to individual licensing agreements. 
  
29
It is difficult, however, to formulate an effective query for these portals: Full-text 
has so much lexical variation that query terms are often too broad or too narrow.  This 
standard information retrieval problem has been extensively researched for queries 
based on titles, abstracts, and indexing terms.  Much less research has been done on 
query expansion and refinement for full-text.  Today's full-text portals offer very basic 
Boolean query interfaces only, with little support for synonyms, stemming, n-grams, or 
"nearby" operations. 
We suggest that open access literature can help users build better queries for 
use within full-text portals.  An increasingly large proportion of the biomedical literature 
is now published in open access journals such as the BMC family, PLoS family, Nucleic 
Acids Research, and the Journal of Medical Internet Research [124].  Papers published 
in these journals can be freely downloaded, redistributed, and preprocessed by anyone 
for any purpose.  Furthermore, the NCBI provides a daily zipped archive of biomedical 
articles published by most open access publishers in a standard format, making it easy 
to establish and maintain a local archive of this content.  If a proposed seed query has 
sufficient coverage, we believe that the open access literature could provide valuable 
information to expand and focus the query when it is applied to the general literature 
though established full-text portals.  
We propose a method to facilitate the retrieval of biomedical literature through 
full-text queries run in publicly accessible interfaces.  In this initial implementation, users 
provided a list of true positive and true negative PubMed identifiers within the open 
access literature. Standard text mining techniques were used to generate a query that 
accurately retrieved the documents based on the provided examples.  We chose text-
mining techniques that resulted in query syntax that was compatible with full-text portal 
interfaces, such as Boolean combinations, n-grams, wildcards, stemming, and stop 
words.  The returned query was ready to be run through the simple interfaces of 
existing, publicly available full-text search engines. Full-text document hits could then be 
manually reviewed and downloaded by the user, subject to article subscription 
restrictions. 
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To evaluate the feasibility of this query-development approach, we applied it to 
the task of identifying studies that use a specific biological wet-laboratory method: 
running gene expression microarray experiments. 
3.2 METHOD 
3.2.1 Query development corpus 
To assemble articles on the general topic of interest, we used the title and abstract filter 
proposed by Ocshner et al. [10].  We limited our results to those in the open access 
literature by running the following PubMed query: 
 
"open access" [filter] AND  
(microarray [tiab] OR microarrays [tiab] OR genome-wide [tiab]  
OR "expression profile" [tiab] OR "expression profiles" [tiab]  
OR "transcription profile" [tiab] OR "transcription profiling" [tiab]) 
 
We translated the returned PubMed identifiers to PubMed Central (PMC) 
identifiers, then to locations on the PubMed Central server. We downloaded the full text 
for the first 4000 files from PubMed Central and extracted the component containing the 
raw text in xml format.  
To automatically classify our development corpus, we used raw dataset sharing 
into NCBI’s Gene Expression Omnibus(GEO) database [125] as a proxy for running 
gene expression microarray experiments.  This approach will incorrectly classify many 
gene-expression data articles, because either the authors did not share their gene 
expression data (about 50% [10]) or they did share but did not have a link to their gene 
expression study in GEO (about 35% [126]).  Nonetheless, we expected the number of 
false negative instances to be small compared to the number of true negatives and thus 
sufficiently accurate for training.  We implemented this filter by querying PubMed 
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Central with the development-corpus identifiers and the filter AND “pmc_gds” [filter], 
using the NCBI’s EUtils web service.  We considered articles returned by this filter to be 
positive examples, or gene expression microarray sharing/creation articles, and articles 
not returned in this subset to be negative examples. 
3.2.2 Query development features 
We assembled unigram and bigram features of the article full-text.  Specifically, we 
removed all xml and split on spaces and all punctuation except hyphens.  We excluded 
any unigram or bigram that included a word less than 3 characters long, more than 30 
characters long, or that did not include at least one alphabetic character.  We excluded 
unigrams and bigrams that included PubMed (and PubMed Central) stop words [127].  
Due to the nature of our specific-use case for the query, we also excluded a manually 
derived list of bioinformatics data words, such as “geo”, “omnibus”, “accession number”, 
“Agilent,” and journal and formatting words, such as “bmc”, “plos”, “dtd”, and “x000b0.” 
We eliminated unigrams and bigrams that did not have at least 20% precision, 
20% recall, and a 35% f-measure on the entire training set. 
3.2.3 Query development algorithm 
Preliminary investigations using established rule-generation algorithms (JRip, Ridor, 
and others) in Weka returned queries with high f-measure but relatively low precision.  
Attempts to alter parameters to achieve high precision and acceptable recall were not 
successful, even with cost-weighted learning.  Therefore, we decided to use a simple 
technique to build our own binary rules:  assemble features with the highest recall joined 
with AND, assemble features with the highest precision joined by OR, and then AND the 
two assemblies together.  This is illustrated in Figure 3.  
 
 
Figure 3:  Method for building boolean queries from text features 
 
 
We determined NOT phrases through a manual error analysis of the false 
positives in the development set. 
3.2.4 Query syntax 
The search syntax supported by established full-text portals is usually not well 
documented.  We read available help files and experimented to determine capabilities, 
limitations, and syntax.  We then translated the derived rules into the slightly different 
syntaxes of each of the query engines:  PubMed Central, Highwire Press, Scirus, and 
Google Scholar. 
3.2.5 Query evaluation corpus 
We evaluated the performance of our derived query against the reference standard 
established by Ochsner et al. [10]. Although many of the reference articles have full-text 
freely available in PubMed Central, none are open access and thus none were in the 
development set. 
Because the emphasis of Ochsner et al. was precision rather than recall, their 
analysis failed to identify a number of true positives.  We searched for these 
misclassifications automatically by identifying whether any of the articles that were 
considered non-data-generating actually had linked database submissions in GEO: an 
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indication that they did in fact generate data.  We also manually examined all 
classification errors. 
3.2.6 Query execution 
We ran our query for all journals that included their complete content in PubMed Central 
first, then Highwire Press, and finally Google Scholar.  This order allowed us to 
maximize the degree to which the query execution could be automated, as per the 
terms of use of the websites.  We ran the queries in each location for articles published 
in 2007. 
We used the EUtils library to automatically execute the query and obtain the 
results from PubMed Central.  For the other query engines, we manually executed the 
query and manually saved the resulting html files on our computer.  We parsed these 
html files with python scripts to extract the citations and submitted the citation lists to the 
PubMed Citation Matcher to obtain PubMed identifier (PMID) lists. 
3.2.7 Query evaluation statistics 
We calculated the precision and recall of the developed filters and compared this 
performance to that of the two most obvious baseline Medical Subject Heading (MeSH) 
filters: 
“Gene Expression Profiling” AND “Oligonucleotide Array Sequence Analysis” 
“Gene Expression Profiling” OR “Oligonucleotide Array Sequence Analysis” 
 
We also used Fisher’s exact test to verify that the filter was indeed adding value.  
For our use case, an eventual study of data sharing prevalence, we hoped to achieve 
recall of at least 50% and precision of at least 90%. 
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3.3 RESULTS 
3.3.1 Queries 
We applied our query-formulation approach to the task of identifying studies that 
performed gene expression microarray experiments.  Using the open access literature 
as a development corpus and links to a gene expression microarray database as a 
proxy endpoint, we derived the full-text queries shown in Table 4. 
 
 
Table 4:  Derived microarray data creation queries for full-text portals 
Portal Query 
PubMed Central ("gene expression" [text] AND "microarray" [text] AND "cell" [text] AND "rna" [text]) 
AND ("rneasy" [text] OR "trizol" [text] OR "real-time pcr" [text])  
NOT ("tissue microarray*" [text] OR "cpg island*" [text]) 
HighWire Press Anywhere in Text, ANY:  ("gene expression"  AND microarray AND cell AND rna) 
AND (rneasy OR trizol OR "real-time pcr") NOT (“tissue microarray*” OR “cpg 
island*”)  
Google Scholar +"gene expression” +microarray  +cell +rna +(rneasy OR trizol OR "real time pcr")  
-"cpg island*" -"tissue microarray*" 
Scirus Anywhere in Text, ALL: ("gene expression"  AND microarray AND cell AND rna)  
(rneasy OR trizol OR "real-time pcr") ANDNOT ("cpg island*" OR "tissue 
microarray*")  
 
3.3.2 Evaluation portal coverage 
Our evaluation corpus spanned 20 journals.  We preferred to execute queries in 
PubMed Central when possible, since it allows automated query and results processing: 
As seen in Table 5, three of the 20 journals have deposited all of their content in 
PubMed Central.  HighWire Press is also easy to use, though it does require manual 
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querying and saving of results.  Eight of the non-PubMed Central journals made their 
articles queryable by HighWire Press.  The remaining journals listed their content in 
Scirus.  Unfortunately, we were unable to reliably query full-text through Scirus, so we 
queried the remaining journals through Google Scholar for this study. 
 
 
Table 5:  Full-text portal coverage of reference journals, by portal preference 
Portal Journal 
PubMed Central Am J Pathol 
 EMBO J 
  PNAS 
Highwire Press Blood 
  Cancer Res. 
  Endocrinology 
  FASEB J 
  J. Biol. Chem. 
  J. Endocrinol. 
  J. Immunol. 
  Mol. Cell. Biol. 
  Mol. Endocrinol. 
Scirus/Google Scholar Cell 
  Molecular Cell 
  Nature 
  Nature Cell Biology 
  Nature Genetics 
  Nature Medicine 
  Nature Methods 
  Science 
 
 
3.3.3 Query performance 
Ochsner et al. [10] identified 768 articles generally related to gene expression 
microarray data.  Through a manual review, they determined that 391 of the articles 
documented the execution of a gene expression microarray experiment for a true 
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positive rate of 51%.  Our query replicated these results with a precision of 83%, recall 
of 62%, and f-measure of 69%.   
Since the emphasis of the Ochsner review was precision rather than recall, we 
found that they were missing quite a few true positives. We searched for these 
misclassifications automatically by identifying whether any of the articles that were 
considered non-data-generating actually had linked database submissions in GEO: an 
indication that they did in fact generate data.  Forty-four articles were reclassified based 
on this analysis.  Our queries found seven of these reclassified articles and missed 37, 
resulting in a precision of 86% and recall of 57%. 
We then manually examined all 41 remaining errors to see if any were due to 
erroneous manual classification.  Based on our manual examination, we reclassified 28 
articles as true positives, a true positive rate of 60%.  Our query retrieved 12 of these 
and missed 18.  Using this gold standard, the queries achieved a precision of 90% (95% 
confidence intervals: 86% to 93%), recall of 56% (52% to 61%), and f-measure of 69%.  
This performance was much improved over chance (p<0.001).  We used the 
performance against this final gold standard for the remaining analyses. 
To investigate if the queries would be effective in each of the full text portals, we 
examined the performance by portal, as shown in  Table 6. 
 
 
Table 6:  Query accuracy by portal source 
 N precision recall f-measure 
PubMed Central 149 96% 50% 65% 
Highwire Press 498 91% 61% 73% 
Google Scholar 121 67% 30% 42% 
Weighted average 768 90% 56% 69% 
 
 
The performance of all of these portals was improved over chance (p < 0.001), 
indicating that even the relatively poor performance of Google Scholar was adding 
value. 
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Finally, we compare the results of the derived query to two naïve queries based 
on Medical Subject Heading (MeSH) terms.  As seen in Table 7, the derived query had 
better precision than either of the MeSH queries at an acceptable recall for our intended 
task. 
 
 
Table 7:  Query accuracy compared to baseline MeSH queries 
 N precision recall f-measure 
“gene expression profiling” [mesh] OR 
“Oligonucleotide Array Sequence Analysis” [mesh] 
768 81% 66% 73% 
“gene expression profiling” [mesh] AND 
“Oligonucleotide Array Sequence Analysis” [mesh] 
768 88% 24% 38% 
Derived query 768 90% 56% 69% 
 
3.4 DISCUSSION 
We described a mechanism for formulating effective queries for use in publicly 
available, established full-text search portals, using the open access literature as 
training material.  As a proof of concept, we applied this approach to a task that requires 
searching the full text of research articles: identifying studies that ran gene expression 
microarray experiments.  The query we derived achieved 90% precision and 56% recall, 
making it a better fit for our intended application than lower-precision baseline MeSH 
queries.  Although the evaluation demonstrates the usefulness of this approach in only 
one situation, we believe the method for deriving full-text queries could have 
widespread potential. 
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Effectively querying full-text is difficult: Synonyms, variant spellings, acronyms, 
and inexperience make it difficult to form effective queries [128].  Although difficult, 
searching full-text is often the only way to identify methods [85], detect harm [129], 
extract detailed data, or identify all of the biomedical concepts or genes explored in the 
study [130, 131].  There is also evidence that searching full-text is more effective than 
searching meta-data or abstracts for identifying articles of overall relevance [132, 133]. 
Domain-specific biomedical NLP and data integration systems, such as 
Textpresso [134], Pharmspresso [135], BioText [81], and BioLit [136], illustrate the 
potential value of accessing, exploring, and analyzing full-text, though none of these 
tools is designed to facilitate searching across domain-independent open-access and 
closed-access biomedical literature.  Other systems have been built to take a 
preassembled corpus of positive and negative examples to build a filter query for 
execution in PubMed [137, 138], but to our knowledge, none suggest an easily 
accessed open-source training set nor result in a full-text query for use in domain-
independent, publicly accessible online portals.  
Existing full-text search portals, such as Google Scholar, Scirus, Highwire Press, 
and PubMed Central, differ in their features and performance [154, 155], though we 
believe their full-text searching capabilities have not yet been compared.   We found 
differences in retrieval performance, but because our dataset was relatively small, it was 
not clear if any differences between portals were due to the portal or the subset of 
journals we searched. 
While portals provide a source of articles, many prohibit systematic downloads 
[139].  Furthermore, it is unclear whether standard licensing agreements and fair use 
allow text mining, “a question on which informed people continue to disagree [157, 158]. 
Luckily, open access articles are available for download and all kinds of reuse.   
Evidence suggests that these articles have similar textual characteristics to traditional 
journal articles [140], and so we used them as a proxy for all articles. 
Our method offers several advantages over alternatives: It is easy to maintain, it 
is free and open to query both open- and subscription-based content, and the user can 
be in direct control of recall/precision balance by setting recall and precision thresholds.  
It does have several limitations, however.  This technique can only identify articles with 
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full-text available for query in full-text portals, although we estimate that this is a 
sizeable amount of the total literature when results from PubMed Central, Highwire 
Press, Scirus, and Google Scholar are aggregated.  A related limitation is that the 
distribution of articles in full-text portals could influence the distribution of retrieved 
articles.  Articles published within the last year are unlikely to be retrieved, since many 
journals take full advantage of the NIH Public Access embargo period [141].  
Furthermore, while a few journals have made their entire back archives digitally 
queryable, we suspect that recall of articles more than 10-years old would be relatively 
poor.   
We also recognize that since this technique uses open access articles as a proxy 
for all articles, our queries would be most refined in areas that are well represented in 
open access articles.  To the extent that there are topics poorly covered by open access 
articles, this technique could have difficulty deriving keywords to find them.   
The system could be expanded in many ways.  Its input could instead involve a 
seed query and a list of "true positive" passages.  Other publicly available resources 
could also be consulted, including the UMLS®, WordNet, MEDLINE fields, and MeSH 
terms.  Active learning might allow for further refinement.  The system could run parts of 
speech analysis or domain-specific named entity recognition on the open access 
training set, if that helped to identify valuable features.  It could extract features only 
from a certain subsection of manuscripts, if there were reason to believe that all relevant 
information would be in the Methods section, for example. The system could be 
enhanced to use bootstrapping to identify phrase variants [88].  Since some portals 
have some wildcard capabilities, we would like to experiment with learning regular 
expressions [142], though there is some evidence that this may not help [143]. Finally, 
more sophisticated natural language processing algorithms would become easier if this 
method were implemented within a system like LingPipe [143]. 
To better understand the relative strengths and weaknesses of this approach, it 
would be informative to compare its performance to other systems and algorithms on a 
standard task, such as the TREC Genomics corpus [86, 133], or a query that has been 
developed just on abstracts [144]. 
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While our system will undoubtedly underperform compared with those at the 
cutting edge of research, we believe it will raise awareness of the constraints in 
mainstream full-text information retrieval and provide a useful tool for today’s 
researchers. 
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4.0  AIM 2B:  RECALL AND BIAS OF RETRIEVING GENE EXPRESSION 
MICROARRAY DATASETS THROUGH PUBMED IDENTIFIERS 
Background 
The ability to locate publicly available gene expression microarray datasets effectively 
and efficiently facilitates the reuse of these potentially valuable resources.  Centralized 
biomedical databases allow users to query dataset metadata descriptions, but these 
annotations are often too sparse and diverse to allow complex and accurate queries.  In 
this study we examined the ability of PubMed article identifiers to locate publicly 
available gene expression microarray datasets, and investigated whether the retrieved 
datasets were representative of publicly available datasets found through statements of 
data sharing in the associated research articles.  
Results 
In a recent article, Ochsner and colleagues identified 397 studies that had generated 
gene expression microarray data.  Their search of the full text of each publication for 
statements of data sharing revealed 203 publicly available datasets, including 179 in the 
Gene Expression Omnibus (GEO) or ArrayExpress databases.  Our scripted search of 
GEO and ArrayExpress for PubMed identifiers of the same 397 studies returned 160 
datasets, including six not found by the original search for data sharing statements.  As 
a proportion of datasets found by either method, the search for data sharing statements 
identified 91.4% of the 209 publicly available datasets, compared to 76.6% found by our 
search for PubMed identifiers.  Searching GEO or ArrayExpress alone retrieved 63.2% 
and 46.9% of all available datasets, respectively.  Studies retrieved through PubMed 
identifiers were representative of all datasets in terms of research theme, technology, 
size, and impact, though the recall was highest for datasets published by the highest-
impact journals. 
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Conclusions 
Searching database entries using PubMed identifiers can identify the majority of publicly 
available datasets.  We urge authors of all datasets to complete the citation fields for 
their dataset submissions once publication details are known, thereby ensuring their 
work has maximum visibility and can contribute to subsequent studies. 
4.1 BACKGROUND 
The number of publicly available biomedical research datasets, such as those based on 
gene expression microarray experiments, continues to increase.  The ability to access 
and process these large datasets enables other scientists to perform their own data 
driven studies, reduces duplicate data collection, allows the study of issues that require 
combining multiple datasets, and facilitates the training of future scientists through the 
analysis of real experimental data.  
To realize these potential benefits, it is necessary that datasets can easily be 
found when needed. Biomedical databases typically include structured data fields 
indicating number of data samples, experimental platform and organism and tissue-type 
or disease of study.  The experimental design, controls, and interventions involved are 
usually described in free-text fields. Unfortunately, the content of these descriptions is 
often sparse and diverse [145].  As a result, although basic queries of the structured 
fields can be effective, more complex queries may require pre-processing steps [146] 
and lack the accuracy required for some applications [147, 148]. 
Many publicly available datasets are associated with rich annotation outside the 
database: the published article describing the primary generation and analysis of the 
data.  Centralized biomedical databases often include a “primary citation” field to link to 
the original published article or articles.  This unambiguous link permits a user to query 
the article metadata, indexing terms, abstracts, or even the full text of the article, and 
then receive links to datasets relevant to the query.  
The usefulness of Medical Subject Heading (MeSH) indexing terms for 
annotating gene expression datasets has been described by Butte and colleagues [147, 
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149, 150].  For example, they found that 53% of gene expression microarray datasets in 
the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus 
(GEO) database were linked to articles with disease related MeSH terms [147], that 
control/intervention gene expression data are publicly available for diseases contributing 
to 30% of all disease-related mortality in the United States }[149], and that 
approximately 10% of microarray experiments in GEO have MeSH terms related to 
pharmacological substances [150].  We expect that the use of MEDLINE annotations for 
dataset retrieval will increase, particularly as combining text and data analysis becomes 
more common [80, 136, 148, 151-154]. 
To identify the links between articles and their accompanying datasets, ideally a 
scientist could simply query PubMed, PubMed Central, or a specialized value added 
interface (e.g. MedMiner [155], BioText [81], or others [156]) and receive links to related 
datasets. This is possible within the Entrez network of databases. By appending “AND 
pubmed_gds [filter]” to any PubMed query, the set of returned articles is limited to those 
identified as a primary citation in a Gene Expression Omnibus GEO DataSet record.  
While viewing PubMed results, selecting “GEO Datasets” in the Database dropdown list 
under “Find related data” in the right-hand column will retrieve the associated datasets.  
The data can then be explored or downloaded.  In many cases, this primary citation 
query process can be automated.  The Entrez databases can be queried through a web 
service eUtilities interface 
(http://www.ncbi.nlm.nih.gov/entrez/query/static/eutils_help.html). Other databases offer 
similar web services or application programming interfaces.  
As with any information retrieval strategy, retrieving datasets through their 
citation field identifiers has limitations.  Not all publicly available datasets are submitted 
to centralized databases, and many are hosted on publisher or laboratory websites.  
Dataset citation fields are often empty because datasets are frequently submitted to 
databases before the research article has been published and assigned a PubMed ID.  
If we use a retrieval strategy based on article metadata, how many datasets are we 
missing?  Are the datasets that are found a representative sample?  If not, what are the 
biases? 
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To address these questions, in this study we have compared searching for 
publicly available datasets through statements of data sharing in published articles as 
reported by Ochsner et al. [10] to searching through queries of centralized databases 
with article PubMed identifiers.  We have focused on gene expression microarray data, 
which is expensive to collect, is often shared, has well established data-sharing 
standards, and is valuable for reuse. The National Center for Biotechnology Information 
(NCBI) Gene Expression Omnibus [125] (GEO) and the European Bioinformatics 
Institute (EBI) ArrayExpress [157] databases have emerged as the dominant centralized 
repositories for sharing gene expression microarray data. Both include fields for primary 
article citations as PubMed IDs and support querying of those links. 
4.2 METHODS 
4.2.1 Reference standard 
Ochsner and colleagues [10] manually curated gene expression microarray studies 
published in 20 journals during 2007.  They began with a PubMed filter to identify 
studies related to gene expression microarray data, reviewed the gene expression 
articles to identify the subset of studies that generated primary gene expression 
datasets, and finally searched the full text of the published research articles for 
statements that the datasets were publicly available either in centralized databases, as 
supplementary information, or on public websites.   
4.2.2 Database search for PubMed identifiers 
We attempted to replicate the results of Ochsner et al. with a scripted query of gene 
expression databases.  We began with their list of PubMed identifiers for articles 
identified as generating primary gene expression datasets.  We then ran scripts to query 
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the “article submission citation” field of the GEO and ArrayExpress databases with this 
list of PubMed IDs, and tabulated the datasets thereby retrieved. 
We issued scripted queries for GEO and ArrayExpress through their web 
programmatic interfaces.  For example, to query GEO for PubMed IDs 17510434 and 
17603471, we wrote programmatically retrieved the following page: 
http://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=(17510434%5Buid%5D
+OR+17603471%5Buid%5D)+AND+pubmed_gds%5Bfilter%5D 
and then extracted the <IDList> from the resulting XML.  To search 
ArrayExpress, we issued a query for each PubMed ID: 
http://www.ebi.ac.uk/microarray-as/ae/xml/experiments?keywords=17510434 
http://www.ebi.ac.uk/microarray-as/ae/xml/experiments?keywords=17603471 
and confirmed the returned pages listed the PubMed ID in the bibliography field.  
We performed these queries with custom Python scripts. 
4.2.3 Data extraction 
For each of the datasets found in centralized databases, we collected the PubMed 
ID(s), the number of samples in the dataset, the gene expression platform, and the 
species. We considered the variable for dataset size to be “missing” for datasets shared 
outside centralized databases because the number of dataset samples was rarely 
explicitly and consistently stated on journal or laboratory websites. 
For each PubMed identifier we collected the name of the journal that published 
the article, its 2007 Thomson ISI Journal Impact Factor, whether the article was indexed 
with the MeSH keyword that identifies cultured cells, and whether the article was found 
by the PubMed “cancer” filter (cancer was the most frequent disease classification for 
microarray data identified by Butte [147]).  We collected PubMed Central citation 
statistics using the Entrez EUtils web service.   
We determined whether each journal published articles within one specific 
discipline or had a multidisciplinary scope.  We also recorded whether the journal 
requires authors to include a gene expression microarray database submission 
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accession number in their articles as a condition of publication, following our earlier 
analysis of journal requirements [16]. 
If identical datasets were found in more than one location, we made note of this 
and collected data for the most complete location.  Data collection was performed in 
May 2009 by manual download and with customized scripts (Python 2.5.2 and the 
EUtils python library [158]. 
4.2.4 Statistical analysis 
We calculated the proportion of datasets that were retrievable by the Ochsner search 
and PubMed identifier queries, using the union of datasets found by either method as a 
denominator.  We estimated the odds that defined subsets of gene expression 
microarray datasets (those investigating cancer, performed on an Affymetrix platform, 
involving humans, or involving cultured cells) would be retrieved by querying a database 
for their PubMed identifiers, relative to the odds they would be found by the Ochsner 
search but overlooked by the scripted query for PubMed identifiers.  Fisher’s exact test 
was used to determine whether the odds were significantly different than 1.0, with 95% 
confidence intervals.  Histograms and Wilcoxon Rank Sum tests were used to 
determine whether the distributions of journal impact factors, number of citations, and 
number of data samples were significantly different between datasets found or 
overlooked by the PubMed identifier query.  Statistics were calculated using the sciplot 
[159], Hmisc, and Design [160] libraries in R version 2.7.0 [108]. 
4.3 RESULTS 
A previous article by Ochsner et al. [10] identified 397 published studies that generated 
gene expression microarray data.  Their examination of data sharing statements 
revealed that 186 (47%) of these studies had made their datasets publicly available.  
Fourteen studies had more than one associated dataset (13 studies had two associated 
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datasets, one study had five).  The combined 203 datasets were found in a variety of 
locations: 147 (72%) in the Gene Expression Omnibus (GEO) database, 32 (16%) in the 
ArrayExpress database, 12 (6%) hosted on journal websites, and 12 (6%) on laboratory 
websites and smaller online data repositories. Combined, GEO and ArrayExpress 
housed 179 (88%) of the datasets found by the Ochsner search. 
In order to determine the effectiveness of retrieving microarray datasets through 
an automated search, we attempted to locate these publicly available datasets using 
scripted queries of centralized microarray databases.  We queried the GEO and 
ArrayExpress databases with the PubMed identifiers of the 397 data producing studies.  
Our scripted queries returned 160 datasets in total: 132 datasets in GEO and 98 
datasets in ArrayExpress, including 70 datasets in both databases (ArrayExpress 
imports selected GEO submissions). 
We compared the retrieval results of the two search strategies: Ochsner‘s search 
for data sharing statements within the full text of the published studies and our query of 
centralized databases for PubMed identifiers.  As shown in Table 8, the query of 
databases using PubMed identifiers returned 6 datasets that were overlooked by 
Ochsner’s search.  Data submission dates suggested that one of these six was 
submitted after publication of the Ochsner paper.  Ochsner’s search found 31 datasets 
in GEO and ArrayExpress that were not found by the PubMed identifier search strategy: 
18 of these database entries listed no article citation, 10 listed a different citation by the 
same research group, two listed incomplete citations lacking a PubMed ID, and one 
dataset entry included citations to papers by what appears to be a different group of 
authors. 
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Table 8: Comparison of dataset retrieval by two retrieval strategies 
a) a search of article full-text for statements of data sharing, and b) a scripted query of 
centralized microarray databases for PubMed identifiers. 
 b) Number of datasets  
Found by querying 
databases for PubMed IDs 
Number of datasets  
Not Found by querying 
databases for PubMed IDs 
Total 
a) Number of datasets 
Found by searching full-
text for statements of 
data sharing 
154 49  
(31 in GEO and 
ArrayExpress  
+ 18 elsewhere) 
203 
Number of datasets  
Not Found by searching 
full-text for statements of 
data sharing 
6 An unknown number of 
data-producing studies have 
publicly available data not 
found by either search 
method 
at least 6 
Total 160 at least 49 at least 209 
 
 
 
The union of retrieval results from both search strategies yielded 209 datasets.  
We defined this union as the set “all publicly available datasets” for subsequent 
analysis. As illustrated in Figure 4, 91% of the 209 publicly available datasets were 
identified by the Ochsner search, compared to 77% found by queries of GEO and 
ArrayExpress for PubMed identifiers.  PubMed identifier queries of either GEO or 
ArrayExpress alone retrieved 63% and 47% of all available datasets, respectively. 
 
 
Figure 4:  Datasets found or missed by PubMed ID queries, by database 
 (bars indicate 95% confidence intervals of proportions) 
 
 
Next, we looked at univariate patterns to determine whether the datasets 
retrieved through our search differed from those found only by the Ochsner search.  The 
odds that a dataset was about cancer, performed on an Affymetrix platform, involved 
humans, or involved cultured cells were not significantly different whether the dataset 
was retrievable through our search method or not (p>0.3).  The recall for datasets from 
disciplinary journals was similar to the recall from multidisciplinary journals (p>0.1).  In 
ANOVA analysis, the distribution of species was not significantly different between the 
two search strategies (p>0.9).   
Datasets found through PubMed identifiers were more likely to be associated 
with articles in higher impact journals than datasets overlooked by this retrieval method 
(p=0.01).  Our PubMed identifier search found 92% of datasets from articles published 
in journals with impact factors greater than 20, 88% of those with impact factors 
between 10 and 20, and 73% of those with impact factors between three and 10.  
Journal data sharing policy and journal scope were strongly associated with journal 
impact factor (p<0.001), but stratifying our dataset by these features only slightly 
reduced the association between impact factor and recall (minimum p-value for stratified 
analysis was 0.06).  
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There was no association between the number of citations received by a study or 
the study sample size and whether or not the dataset was found by our PubMed 
identifier query.  Histograms of the impact factors (Figure 5a), citations (Figure 5b), and 
dataset sample size (Figure 5c) found and overlooked by our query illustrate these 
patterns. 
 
(a) 
 
(b) 
 
(c) 
 
Figure 5:  Datasets found or missed by PubMed ID queries, by impact and size 
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The ability to retrieve online datasets through PubMed identifiers differed across 
the twenty journals in our sample, as illustrated in Figure 6, although this difference was 
not statistically significant in an ANOVA test (p=0.9).  
 
 
 
Figure 6:  Datasets found or missed by PubMed ID queries, by journal 
(bars indicate 95% confidence intervals of proportions) 
 
In Figure 6, light grey bars represent the proportion of online datasets available in 
the Gene Expression Omnibus or ArrayExpress databases.  Dark grey bars represent 
the proportion of online datasets that include their publication PubMed identifier in the 
GEO or ArrayExpress entry, and thus can be found by our retrieval method.  The 
number of online datasets in our sample follows the journal title, in parentheses. 
Finally, we found some evidence that journal policy may be associated with 
whether a dataset is deposited into a database, complete with PubMed identifier 
citation.  Our scripted queries found 78% of known publicly available datasets for 
articles published in journals that require a GEO or ArrayExpress submission accession 
number as a condition of publication.  This is a higher retrieval rate than we found for 
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publicly available datasets in journals without such a policy (65%), but the difference 
was not statistically significant (p=0.19).   
4.4 DISCUSSION 
In this study we found that scripted queries of centralized microarray databases using 
PubMed identifiers retrieved 76.6% of all publicly available datasets associated with the 
publications.  The spectrum of datasets was similar to that found by a reference search 
[10] in terms of array platform, cell source, subject of study, sample size, and study 
impact. 
Dataset retrieval through PubMed identifiers achieved the highest recall when 
applied to studies from the highest-impact journals.  Additional research is needed to 
understand the reasons behind this finding since it is not fully explained by journal policy 
or scope, and may have to do with the implementation details of journal policy 
requirements.  The importance of the retrieval bias depends on the intended use of the 
query results.  For example, while there is likely no problem using the query to retrieve 
datasets for a combination analysis, caution is required when using the results for policy 
evaluation because query results are not fully representative of all online datasets,  
Our evaluation has several limitations.  The evaluation dataset was not chosen 
randomly and does not contain a representative distribution of journals:  in particular, 
our evaluation subset lacked any journal with an impact factor below 2.5.  Also, our 
reference standard classifications may contain errors, if there exist studies with publicly 
available data that were identified by neither the Ochsner search nor our PubMed 
identifier query. 
We found that the number of gene expression microarray dataset entries with 
citation links could be increased by about 25% if all datasets now published on the 
internet were uploaded to centralized databases, and all primary article citation fields 
were fully completed.  This is consistent with the findings of manual update efforts on 
the PDB database [57, 161].  We believe encouraging authors and enabling curators to 
document all link between datasets and research articles is effort well spent.  In addition 
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to use in retrieval, a clear relationship between a dataset and its research article allows 
synergistic documentation, integration for text mining and data mining, and facilitates 
rewards for publicly sharing data [162, 163]. 
This study considers the issue of retrieving datasets that are currently available 
on the internet.  As noted by Ochsner et al., data from half of the published gene 
expression microarray studies does not appear to be publicly shared online [10].  
Addressing incentives and policies for increasing the proportion of publicly available 
datasets is outside the scope of the current study but represents a crucial issue for 
unleashing the potential of research resources. 
4.5 CONCLUSIONS 
Efficient and accurate dataset retrieval can improve the efficiency of scientific progress, 
to the extent that it permits detailed review, facilitates integration, and reduces duplicate 
data collection. Our study suggests that querying gene expression microarray 
databases for PubMed identifiers is a feasible approach for identifying the majority of 
publication-related publicly available datasets, particularly when results from GEO and 
ArrayExpress are combined.  The retrieved datasets are representative of all related 
publicly available datasets.  We urge the authors of all datasets to complete the citation 
fields for their dataset submissions once publication details are known, thereby ensuring 
their work can have maximum visibility and fully contribute to future scientific studies.  
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5.0  AIM 3:  WHO SHARES?  WHO DOESN’T?  FACTORS ASSOCIATED WITH 
SHARING GENE EXPRESSION MICROARRAY DATA 
Many initiatives encourage research investigators to share their raw research datasets 
in hopes of increasing research efficiency and quality. Despite these investments of 
time and money, we do not have a firm grasp on the prevalence or patterns of data 
sharing and reuse; the effectiveness of initiatives; or the costs, benefits, and impact of 
repurposing biomedical research data.  Previous survey methods for understanding 
data sharing patterns provide insight into investigator attitudes, but do not facilitate 
direct measurement of data sharing behaviour or its correlates.  In this study, we use 
bibliometric methods to understand the prevalence and patterns with which 
investigators publicly share their raw gene expression microarray datasets after study 
publication. 
We used automated methods to identify 11,603 publications that created gene 
expression microarray data and estimated that the authors of at least 25% of these 
publications deposited their data in the predominant public databases.  We collected a 
wide set of variables about these studies and derived 15 factors that describe 
authorship, funding, institution, publication, and domain environments.  Most factors 
were found to be statistically associated with the prevalence of data sharing.  In 
particular, publishing in a journal with a relatively strong data sharing policy, having 
funding from many NIH grants, publishing in an open access journal, and having prior 
experience sharing data were associated with the highest data sharing rates.  In 
contrast, increased first author age and experience, having no experience reusing data, 
and studying cancer and human subjects were associated with the lowest data sharing 
rates.  
  
55
In second-order analysis, previously sharing gene expression data was most 
positively associated with high data sharing rates, whereas publishing a study on cancer 
or human subjects was strongly associated with a negative probability of data sharing. 
We hope these methods and results will contribute to a deeper understanding of 
data sharing behavior and eventually more effective data sharing initiatives. 
5.1 INTRODUCTION 
Sharing and reusing primary research datasets has the potential to increase research 
efficiency and quality. Raw data can be used to explore related or new hypotheses, 
particularly when combined with other available datasets. Real data is indispensable for 
developing and validating study methods, analysis techniques, and software 
implementations. The larger scientific community also benefits: Sharing data 
encourages multiple perspectives, helps to identify errors, discourages fraud, is useful 
for training new researchers, and increases efficient use of funding and population 
resources by avoiding duplicate data collection. 
Eager to realize these benefits, funders, publishers, societies, and individual 
research groups have developed tools, resources, and policies to encourage 
investigators to make their data publicly available. For example, some journals require 
the submission of detailed biomedical datasets to publicly available databases as a 
condition of publication [15, 16]. Many funders require data sharing plans as a condition 
of funding: Since 2003, the National Institutes of Health (NIH) in the USA has required a 
data sharing plan for all large funding grants [17] and has more recently introduced 
stronger requirements for genome-wide association studies [164].  Several government 
whitepapers [14, 19] and high-profile editorials [165, 166] call for responsible data 
sharing and reuse.  Large-scale collaborative science is increasing the need to share 
datasets [20, 167], and many guidelines, tools, standards, and databases are being 
developed and maintained to facilitate data sharing and reuse [120, 125].  
Despite these investments of time and money, we do not yet understand the 
impact of these initiatives.  There is a well-known adage: You cannot manage what you 
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do not measure. For those with a goal of promoting responsible data sharing, it would 
be helpful to evaluate the effectiveness of requirements, recommendations, and tools. 
When data sharing is voluntary, insights could be gained by learning which datasets are 
shared, on what topics, by whom, and in what locations. When policies make data 
sharing mandatory, monitoring is useful to understand compliance and unexpected 
consequences. 
Dimensions of data sharing action and intension have been investigated by a 
variety of studies.  Manual annotations and systematic data requests have been used to 
estimate the frequency of data sharing within biomedicine [10, 11, 51, 117], though few 
attempts were made to determine patterns of sharing and withholding within these 
samples.  Blumenthal [13], Campbell [52], Hedstrom [168], and others have used 
survey results to correlate self-reported instances of data sharing and withholding with 
self-reported attributes like industry involvement, perceived competitiveness, career 
productivity, and anticipated data sharing costs.  Others have used surveys and 
interviews to analyze opinions about the effectiveness of mandates [53] and the value of 
various incentives [168-171].  A few inventories list the data-sharing policies of funders 
[172, 173] and journals [15, 174], and some work has been done to correlate policy 
strength with outcome [16, 175].  Surveys and case studies have been used to develop 
models of information behavior in related domains, including knowledge sharing within 
an organization [191, 192], physician knowledge sharing in hospitals [176], participation 
in open source projects [177], academic contributions to institutional archives [56, 178], 
the choice to publish in open access journals [179], sharing social science datasets 
[168], and participation in large-scale biomedical research collaborations [54]. 
Although these studies provide valuable insights and their methods facilitate 
investigation into an author’s intentions and opinions, they have several limitations.  
First, associations between an investigator’s intention to share data do not directly 
translate to an association with actually sharing data [180].  Second, associations that 
rely on self-reported data sharing and withholding likely suffer from underreporting and 
confounding, since people admit withholding data much less frequently than they report 
having experienced the data withholding of others [13]. 
  
57
We suggest a supplemental approach for investigating research data-sharing 
behavior.  We have collected and analyzed a large set of observed data sharing actions 
and associated study, investigator, journal, funding, and institutional variables. In this 
report we explore common factors behind these attributes and look at the association 
between these factors and data sharing prevalence. 
We chose to study data sharing for one particular type of data: biological gene 
expression microarray intensity values.  Microarray studies provide a useful 
environment for exploring data sharing policies and behaviors.  Despite being a rich 
resource valuable for reuse [181], microarray data are often, but not yet, universally 
shared.  Best-practice guidelines for sharing microarray data are fairly mature [120, 
182].  Two centralized databases have emerged as best-practice repositories: the Gene 
Expression Omnibus (GEO) [125] and ArrayExpress [157].  Finally, high-profile letters 
have called for strong journal data-sharing policies [34], resulting in unusually strong 
data sharing requirements in some journals [183]. 
5.2 METHODS 
We identified a set of studies in which the investigators had generated gene expression 
microarray datasets, and then we identified the subset that had made their datasets 
publicly available on the internet. We analyzed attributes related to the investigators, 
journals, funding, institutions, and topic of the studies to determine which factors were 
associated with an increased frequency of data sharing.  
5.2.1 Studies for analysis 
The set of “gene expression microarray creation” articles was identified by searching the 
full-text of PubMed Central, Highwire Press, Scirus, and Google Scholar with portal-
specific variants of the following query: 
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("gene expression"  AND "microarray"  AND "cell"  AND "rna" )  
AND ("rneasy"  OR "trizol"  OR "real-time pcr" )  
NOT ("tissue microarray*"  OR "cpg island*") 
 
We found PubMed identifiers for the retrieved articles whenever possible and 
considered the union of these PubMed identifiers to be our studies for analysis.  As 
discussed in Chapter 3, we previously evaluated the accuracy of this approach and 
found that it identified articles that created microarray data with a precision of 90% (95% 
confidence interval, 86% to 93%) and a recall of 56% (52% to 61%), compared to 
manual identification of articles that created microarray data. 
Because Google Scholar only allows viewing of 1000 results per query, we were 
not able to identify all of its hits.  We tried to identify as many as possible by iteratively 
appending a variety of attributes to the end of the query, including various publisher 
names, journal title words, and years of publication, thereby retrieving distinct subsets of 
the results 1000 hits at a time. 
5.2.2 Study attributes 
Our dependant variable was whether the gene expression microarray research articles 
had an associated dataset in a public centralized repository.  As we showed in Chapter 
4, we found that querying the NCBI’s Gene Expression Omnibus and EBI’s 
ArrayExpress with article PubMed identifiers located a representative 77% of all publicly 
available datasets associated with the published articles.  
We implemented this same approach on the study articles; we queried GEO by 
submitting our PubMed identifiers to PubMed, then filtering them using the  
“pubmed_gds [filter]” query.  We queried ArrayExpress by searching for each PubMed 
identifier in an offline copy of their public database.  Those articles with an associated 
dataset in one of these two centralized repositories were considered to have “shared 
their data” for our endpoint, and those without such a link were considered not to have 
shared their data. 
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For every study article, we collected 124 attributes that were used as 
independent variables, as listed in the Appendix. The independent variables were 
collected automatically from a wide variety of sources.  Basic bibliometric metadata was 
extracted from the MEDLINE record, including journal, year of publication, number of 
authors, Medical Subject Heading (MeSH) terms, number of citations from PubMed 
Central, inclusion in PubMed subsets for cancer, whether the journal is published with 
an open-access model and if it had data-submission links from Genbank, PDB, and 
SwissProt.  The corresponding address was parsed for institution and country, following 
the methods of Yu et al.[184]. 
Institutions were cross-referenced to the SCImago Institutions Rankings 2009 
World Report(http://www.scimagoir.com/) to estimate the relative degree of research 
output and impact of the institutions.  The gender of the first and last authors were 
estimated using the Baby Name Guesser website at 
http://www.gpeters.com/names/baby-names.php.  ISI Journal Impact Factors and 
associated metrics were extracted from the 2008 ISI Journal Citation Reports. 
NIH grant details were extracted by cross-referencing grant numbers in the 
MEDLINE record with the NIH award information at 
http://report.nih.gov/award/state/state.cfm.  From this information, we tabulated the 
amount of total funding received for each of the fiscal years from 2003 to 2008. We also 
estimated the date of renewal by identifying the most recent year in which a grant 
number was prefixed by a “1” or “2” —indication that the grant is “new” or “renewed,” 
respectively. 
We quantified the content of journal data-sharing policies based on the 
“Instruction for Authors” for the most commonly occurring journals.  We attempted to 
estimate if the paper itself reused publicly available gene expression microarray data by 
looking for its inclusion in the list that GEO keeps of reuse at 
http://www.ncbi.nlm.nih.gov/projects/geo/info/ucitations.html.  
A list of prior publications in MEDLINE was extracted from Author-ity clusters, 
2009 edition [185], for the first and last author of each article in our study.  To limit the 
impact of extremely large “lumped” clusters that erroneously contain the publications of 
more than one actual author, we excluded prior publication lists for first or last authors in 
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the largest 2% of clusters and instead considered this data to be missing.  For all 
papers in an author’s publication history with PubMed identifiers numerically less than 
the PubMed identifier of the paper in question, we queried for whether any of these prior 
publications had been published in an open source journal, were included in our “gene 
expression microarray creation” subset themselves, or had reused gene expression 
data.  We recorded the date of the earliest publication by the author and the number of 
citations to date that their earlier papers received in PubMed Central. 
Data collection scripts were coded in Python version 2.5.2 (many libraries, 
including EUtils, BeautifulSoup, pyparsing and nltk [186]) and SQLite version 3.4. 
5.2.3 Statistical methods 
Statistical analysis was performed in R version 2.10.1 [108].  P-values were two-tailed.  
Data was visually explored using Mondrian version 1.1 [187] and the Hmisc package 
[188].  We applied a square-root transformation to variables representing count data to 
improve their normality prior to calculating correlations.  
To calculate variable correlations, we used the hector function in the polycor 
library.  This computes polyserial correlations between pairs of numeric and ordinal 
variables and polychoric correlations between two ordinal variables.  We modified it to 
calculate Pearson correlations between numeric variables using the rcorr function in the 
Hmisc library.  We used a pairwise-complete approach to missing data and used the 
nearcor function in the sfsmisc library to make the correlation matrix positive definite.  A 
correlation heatmap was produced using the gplots library. 
We used the nFactors library to calculate and display the scree plot for our 
correlations. 
Since our correlation matrix was not well-behaved enough for maximum-
likelihood factor analysis, first-order exploratory factor analysis was performed with the 
fa function in the psych library, using the minimum residual (minres) solution and a 
promaxoblique rotation.  Second-order factor analysis also used the minres solution but 
a varimax rotation, since we wanted these factors to be orthogonal.  We computed the 
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loadings on the original variables for the second-order factors using the method 
described by Gorsuch[189]. 
To compute the factor scores for the original dataset, we first had to impute the 
missing values.  We did this using Gibbs sampling with two iterations through the mice 
library. 
Using this complete dataset, we computed scores for each of our datapoints onto 
all of the first and second-order factors using Bartlett’s algorithm as extracted from the 
factanal function.  We submitted these factor scores to a logistic regression using the 
lrm function in the rms package.  Continuous variables were modeled as cubic splines 
with 4 knots using the rcs function from the rms package, and all two-way interactions 
were explored. 
Finally, we performed hierarchical supervised clustering on the datapoints to 
learn which factors were most predictive and then estimated the data sharing 
prevalence in a contingency table of these two clusters split at their medians. 
5.3 RESULTS 
Our queries for identifying microarray data-producing articles returned PubMed 
identifiers for 11,603 studies. 
MEDLINE fields were still “in process” for 512 records, resulting in missing data 
for our MeSH-derived variables (Human, Mice, effectiveness, etc.). Impact factors were 
found for all but 1,001 articles.  Journal policy variables were missing for 4,107 articles.  
The institution ranking attributes were missing for 6,185.  We cross-referenced NIH 
grant details for 3,064 studies (some grant numbers could not be parsed, because they 
were incomplete or strangely formatted). We were able to determine the gender of the 
first and last authors, based on the forenames in the MEDLINE record, for all but 2,841 
first authors and 2,790 last authors.  All but 1,765 first authors and 797 last authors 
were found to have a publication history in the 2009 Author-ity clusters.  A summary of 
the variables can be found in the Appendix and their correlations in Figure 7. 
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PubMed identifiers were found in GEO or ArrayExpress primary citation fields for 
2,901 of the 11,603 articles in our dataset, indicating that 25% (95% confidence 
intervals: 24% to 26%) of the studies deposited their data in GEO or ArrayExpress and 
completed the “citation” fields with the primary article PubMed identifier.  This is our 
estimate for the prevalence of gene expression microarray data deposited into the two 
predominant, centralized, publicly accessible databases.  This data-sharing rate 
increased with each subsequent article publication year, as seen in Figure 8.  The data 
sharing rate also varied across journals. Figure 9 shows the data sharing rate across 
the 50 journals with the most studies in our dataset. 
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Figure 7:  Covariance matrix of independent variables.   
Positive
 
 correlations are red and negative correlations are blue. 
 
  
Figure 8:  Proportion of articles with shared datasets, by year 
(error bars are 95% confidence intervals of the proportions) 
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Figure 9:  Proportion of articles with shared datasets, by journal 
(error bars are 95% confidence intervals of the proportions) 
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Many of our other attributes were also associated with the prevalence of data 
sharing in univariate analysis.  Illustrations of these relationships are given in the 
Appendix. 
5.3.1 First-order factors 
We tried to use a scree plot to determine the number of factors for our first-order 
analysis.  Since the scree plot did not have a clear drop-off, we experimented with a 
range of factor counts near the optimal coordinates index (as calculated by nScree in 
the nFactors R-project library) and finalized on 15 factors.  Our correlation matrix was 
not sufficiently well-behaved for maximum-likelihood factor analysis, so we used a 
minimum residual (minres) solution.  We chose to rotate our factors with the promax 
oblique algorithm, because we expected our first-order factors to have significant 
correlations with one another.  The rotated first-order factors are given in Table 9 with 
loadings larger than 0.4 or less than -0.4.  We named the factors based on the variables 
they load most heavily, using abbreviations for publishing in an Open Access journal 
(OA) and previously depositing data in the Gene Expression Omnibus (GEO) or 
ArrayExpress (AE) databases. 
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Table 9:  First-order factor loadings 
Large NIH grant 
    0.97 num.post2005.morethan1000k.tr 
    0.96 num.post2005.morethan750k.tr 
    0.92 num.post2004.morethan750k.tr 
    0.91 num.post2004.morethan1000k.tr 
    0.91 num.post2005.morethan500k.tr 
    0.89 num.post2006.morethan1000k.tr 
    0.89 num.post2006.morethan750k.tr 
    0.86 num.post2004.morethan500k.tr 
    0.85 num.post2006.morethan500k.tr 
    0.84 num.post2003.morethan750k.tr 
    0.84 num.post2003.morethan1000k.tr 
    0.80 num.post2003.morethan500k.tr 
    0.74 has.U.funding 
    0.71 has.P.funding 
    0.58 nih.sum.avg.dollars.tr 
    0.56 nih.sum.sum.dollars.tr 
    0.44 nih.max.max.dollars.tr 
 
Has journal policy 
    1.00 journal.policy.contains..geo.omnibus 
    0.95 journal.policy.at.least.requests.sharing.array 
    0.95 journal.policy.mentions.any.sharing 
    0.93 journal.policy.contains.word.microarray 
    0.91 journal.policy.requests.sharing.other.data 
    0.85 journal.policy.says.must.deposit 
    0.83 journal.policy.contains.word.arrayexpress 
    0.72 journal.policy.requires.microarray.accession 
    0.71 journal.policy.requests.accession 
    0.58 journal.policy.contains.word.miame.mged 
    0.48 journal.microarray.creating.count.tr 
    0.45 journal.policy.mentions.consequences 
    0.42 journal.policy.general.statement 
 
NOT institution NCI or intramural 
    0.59 pubmed.is.funded.non.us.govt 
    0.55 institution.is.higher.ed 
   -0.89 institution.nci 
   -0.86 pubmed.is.funded.nih.intramural 
   -0.42 country.usa 
 
Count of R01 & other NIH grants 
    1.15 has.R01.funding 
    1.14 has.R.funding 
    0.89 num.grants.via.nih.tr 
    0.86 nih.cumulative.years.tr 
    0.82 num.grant.numbers.tr 
    0.80 max.grant.duration.tr 
    0.66 pubmed.is.funded.nih 
    0.50 nih.max.max.dollars.tr 
    0.45 num.nih.is.nigms.tr 
    0.44 country.usa 
    0.42 has.T.funding 
    0.41 num.nih.is.niaid.tr 
 
Journal impact 
   0.88 journal.5yr.impact.factor.log 
    0.88 journal.impact.factor.log 
    0.85 journal.immediacy.index.log 
    0.70 journal.policy.mentions.exceptions 
    0.54 journal.num.articles.2008.tr 
    0.51 journal.policy.contains.word.miame.mged 
   -0.61 journal.policy.contains.word.arrayexpress 
   -0.48 pubmed.is.open.access 
 
Last author num prev pubs & first year pub 
    0.84 last.author.num.prev.pubs.tr 
    0.74 last.author.year.first.pub.ago.tr 
    0.73 last.author.num.prev.pmc.cites.tr 
    0.68 last.author.num.prev.other.sharing.tr 
    0.48 country.japan 
    0.44 last.author.num.prev.microarray.creations.tr 
 
Journal policy consequences & long half-life 
    0.78 journal.policy.mentions.consequences 
    0.73 journal.cited.halflife 
    0.60 pubmed.is.bacteria 
    0.42 journal.policy.requires.microarray.accession 
   -0.54 pubmed.is.open.access 
   -0.45 journal.policy.general.statement 
 
Institution high citations & collaboration 
    0.76 institution.mean.norm.citation.score 
    0.72 institution.international.collaboration 
    0.64 institution.mean.norm.impact.factor 
    0.41 country.germany 
   -0.67 country.china 
   -0.61 country.korea 
   -0.56 last.author.gender.not.found 
   -0.43 country.japan 
 
continued…
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Table 9 (continued) 
 
NO geo reuse & YES high institution output 
    0.66 institution.research.output.tr 
    0.58 institution.harvard 
    0.46 has.K.funding 
    0.42 institution.stanford 
   -0.79 pubmed.is.geo.reuse 
   -0.62 country.australia 
   -0.46 institution.rank 
 
NOT animals or mice 
    0.51 pubmed.is.humans 
    0.43 pubmed.is.diagnosis 
    0.40 pubmed.is.effectiveness 
   -0.93 pubmed.is.animals 
   -0.86 pubmed.is.mice 
 
Humans & cancer 
    0.84 pubmed.is.humans 
    0.75 pubmed.is.cancer 
    0.67 pubmed.is.cultured.cells 
    0.52 institution.is.medical 
    0.47 pubmed.is.core.clinical.journal 
   -0.68 pubmed.is.plants 
   -0.49 pubmed.is.fungi 
 
Institution is government & NOT higher ed 
    0.92 institution.is.govnt 
    0.70 country.germany 
    0.65 country.france 
    0.46 institution.international.collaboration 
   -0.78 institution.is.higher.ed 
   -0.56 country.canada 
   -0.51 institution.stanford 
   -0.42 institution.is.medical 
 
NO K funding or P funding 
    0.56 has.R01.funding 
    0.49 has.R.funding 
    0.41 num.post2006.morethan500k.tr 
    0.41 num.post2006.morethan750k.tr 
    0.40 num.post2006.morethan1000k.tr 
   -0.65 has.K.funding 
   -0.63 has.P.funding 
 
Authors prev GEOAE sharing & OA & arry creation 
    0.83 last.author.num.prev.geoae.sharing.tr 
    0.74 last.author.num.prev.microarray.creations.tr 
    0.73 last.author.num.prev.oa.tr 
    0.60 first.author.num.prev.geoae.sharing.tr 
    0.47 first.author.num.prev.oa.tr 
    0.46 first.author.num.prev.microarray.creations.tr 
    0.40 institution.stanford 
   -0.44 years.ago.tr 
 
First author num prev pubs & first year pub 
    0.83 first.author.num.prev.pubs.tr 
    0.77 first.author.year.first.pub.ago.tr 
    0.73 first.author.num.prev.pmc.cites.tr 
    0.52 first.author.num.prev.other.sharing.tr 
 
 
After imputing missing values, we calculated scores for each of the 15 factors for 
each of our 11,603 datapoints.   In univariate analysis, several of the factors 
demonstrated a correlation with frequency of data sharing, as seen in Figure 10.  
Several factors seemed to have a linear relationship with data sharing across their 
whole range.  For example, whereas the data sharing rate was relatively low for studies 
that had the lowest score on the factor “Authors prev GEOAE sharing & OA & 
microarray creation” (in Figure 10, the first line under the heading “Authors prev GEOA 
sharing…”), the data sharing rate was higher for studies that had scores within the 25th 
to 50th percentile of all the studies in our sample, higher still for studies with “Authors 
prev GEO sharing…” factor scores in the third quartile, and studies that had a very high 
score on the factor, above the 75th percentile, had a relatively high rate of data sharing.  
A trend in the opposite direction can be seen for the factor “Humans & cancer”:  the 
higher a study scored on that factor, the less likely they were to have shared their data. 
 
 
Figure 10: Association between shared data and first-order factors 
Percentage of studies with shared data is shown for each quartile for each factor.  
Univariate analysis. 
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Most of these factors were significantly associated with data-sharing behavior in 
a multivariate logistic regression: p=0.18 for "Large NIH grant", p<0.05 for "No GEO 
reuse & YES high institution output" and "No K funding or P funding", and p<0.005 for 
the other first-order factors.  The increase in odds of data sharing is illustrated in Figure 
11, as each factor in the model is moved from its 25th percentile value to its 75th 
percentile value. 
 
 
Figure 11: Odds ratios of data sharing for first-order factor, multivariate model 
Odd ratios are calculated as factor scores are each varied from  
their 25th percentile value to their 75th percentile value. 
Horizontal lines show the 95% confidence intervals of the odds ratios.   
 
5.3.2 Second-order factors 
The heavy correlations between these factors suggest that second-order factors may be 
illuminating.  Scree plot analysis of the correlations between the first-order factors 
suggested that we explore a solution containing five second-order factors.  We 
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calculated the factors using a “varimax” rotation to find orthogonal factors.  The loadings 
on the first-order factors are given in Table 10. 
 
Table 10:  Second-order factor loadings, by first-order factors 
Amount of NIH funding 
    0.88 Count of R01 & other NIH grants 
    0.49 Large NIH grant 
   -0.55 NO K funding or P funding 
 
Cancer & humans 
    0.83 Humans & cancer 
 
OA journal & previous GEO-AE sharing 
    0.59 Authors prev GEOAE sharing & OA & microarray creation 
    0.43 Institution high citations & collaboration 
    0.31 First author num prev pubs & first year pub 
   -0.36 Last author num prev pubs & first year pub 
 
Journal impact factor and policy 
    0.57 Journal impact 
    0.51 Last author num prev pubs & first year pub 
 
Higher Ed in USA 
    0.40 NO geo reuse + YES high institution output 
   -0.44 Institution is government & NOT higher ed 
 
Since interactions make these second-order variables slightly difficult to interpret, 
we followed the method explained by Gorsuch [189] to calculate the loadings of the 
second-order variables directly on the original variables.  The results are listed in Table 
11.  We named the second-order factors based on the loadings on the original 
variables. 
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Table 11:  Second-order factor loadings, by original variables 
Amount of NIH funding 
    0.87 nih.cumulative.years.tr 
    0.85 num.grants.via.nih.tr 
    0.84 max.grant.duration.tr 
    0.82 num.grant.numbers.tr 
    0.80 pubmed.is.funded.nih 
    0.79 nih.max.max.dollars.tr 
    0.70 nih.sum.avg.dollars.tr 
    0.70 nih.sum.sum.dollars.tr 
    0.59 has.R.funding 
    0.59 num.post2003.morethan500k.tr 
    0.58 country.usa 
    0.58 has.U.funding 
    0.57 has.R01.funding 
    0.55 num.post2003.morethan750k.tr 
    0.53 has.T.funding 
    0.53 num.post2003.morethan1000k.tr 
    0.49 num.post2004.morethan500k.tr 
    0.45 num.post2004.morethan750k.tr 
    0.44 has.P.funding 
    0.43 num.post2004.morethan1000k.tr 
    0.43 num.nih.is.nci.tr 
    0.35 num.post2005.morethan500k.tr 
    0.32 num.nih.is.nigms.tr 
    0.31 num.post2005.morethan750k.tr 
 
Cancer & humans 
    0.60 pubmed.is.cancer 
    0.59 pubmed.is.humans 
    0.52 pubmed.is.cultured.cells 
    0.43 pubmed.is.core.clinical.journal 
    0.39 institution.is.medical 
   -0.58 pubmed.is.plants 
   -0.50 pubmed.is.fungi 
   -0.37 pubmed.is.shared.other 
   -0.30 pubmed.is.bacteria 
 
OA journal & previous GEO-AE sharing 
    0.40 first.author.num.prev.geoae.sharing.tr 
    0.37 pubmed.is.open.access 
    0.37 first.author.num.prev.oa.tr 
    0.35 last.author.num.prev.geoae.sharing.tr 
    0.32 pubmed.is.effectiveness 
    0.32 last.author.num.prev.oa.tr 
    0.31 pubmed.is.geo.reuse 
   -0.38 country.japan 
 
Journal impact factor and policy 
    0.48 journal.impact.factor.log 
    0.47 jour.policy.requires.microarray.accession 
    0.46 jour.policy.mentions.exceptions 
    0.46 pubmed.num.cites.from.pmc.tr 
    0.45 journal.5yr.impact.factor.log 
    0.45 jour.policy.contains.word.miame.mged 
    0.42 last.author.num.prev.pmc.cites.tr 
    0.41 jour.policy.requests.accession 
    0.40 journal.immediacy.index.log 
    0.40 journal.num.articles.2008.tr 
    0.39 years.ago.tr 
    0.36 jour.policy.says.must.deposit 
    0.35 pubmed.num.cites.from.pmc.per.year 
    0.33 institution.mean.norm.citation.score 
    0.32 last.author.year.first.pub.ago.tr 
    0.31 country.usa 
    0.31 last.author.num.prev.pubs.tr 
    0.31 jour.policy.contains.word.microarray 
   -0.31 pubmed.is.open.access 
 
Higher Ed in USA 
    0.36 institution.stanford 
    0.36 institution.is.higher.ed 
    0.35 country.usa 
    0.35 has.R.funding 
    0.33 has.R01.funding 
    0.30 institution.harvard 
   -0.37 institution.is.govnt 
 We then calculated factor scores for each of these second-order factors using 
the original attributes of our 11,603 datapoints.  In univariate analysis, scores on several 
of the five factors showed a clear linear relationship with data sharing frequency, as 
illustrated in Figure 12. 
 
 
Figure 12: Association between shared data and second-order factors 
Percentage of studies with shared data is shown for each quartile for each factor.  
Univariate analysis. 
 
 
All five of the second-order factors were associated with data sharing in 
multivariate logistic regression, p<0.001.The increase in odds of data sharing is 
illustrated in Figure 13, as each factor in the model is moved from its 25th percentile 
value to its 75th percentile value. 
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Figure 13: Odds ratios of data sharing for second-order factor, multivariate model 
Odd ratios are calculated as factor scores are each varied from  
their 25th percentile value to their 75th percentile value. 
Horizontal lines show the 95% confidence intervals of the odds ratios. 
 
 
Finally, to understand which of these factors is most predictive of data sharing 
behaviour, we performed supervised hierarchical clustering using our second-order 
factors.  Splits on “OA journal & previous GEO-AE sharing” and “Cancer & Humans” 
were clearly the most informative, so we simply split these two factors at their medians 
and looked at the data sharing prevalence.  As shown in Table 12, studies that scored 
high on the “OA journal & previous GEO-AE sharing” factor and low on the “Cancer & 
Humans” factor were almost three times as likely to share their data, compared to a 
“Cancer & Humans” study published without a strong “OA journal & previous GEO-AE 
sharing” background. 
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Table 12:  Data sharing prevalence by two second-order factors  
95% confidence intervals in brackets.   
 
number of studies with shared data/ 
number of studies 
Above the median 
value for the factor  
“Cancer & Humans” 
Below the median 
value for the factor 
“Cancer & Humans” 
Total 
Above the median value for the factor 
“OA and previous GEO-AE sharing” 
626/2614 = 
24% [22%, 26%] 
1193/3187 = 
37% [36%, 39%] 
1819/5801 =  
31% [30%, 33%] 
Below the median value for the factor 
“OA and previous GEO-AE sharing” 
428/3187 = 
13% [12%, 15%] 
654/2615 = 
25% [23%, 27%] 
1082/5802 =  
19% [18%, 20%] 
Total 1054/5801 =  
18% [17%, 19%] 
1847/5802 = 
32% [31%, 33%] 
2901/11603 = 
25% [24%, 26%] 
 
5.4 DISCUSSION 
This study explored the association between attributes of a published experiment and 
the probability that its raw data was shared in a publicly accessible database.  We found 
that 25% of studies that perform gene expression microarray experiments have 
deposited their raw research data in a primary public repository.  The proportion of 
studies that shared their gene expression datasets increased over time, from less than 
5% in early years, before mature standards and repositories, to over 30% in 2009.  
Many factors derived from an experiment’s topic, impact, funding, publishing, 
institutional, and authorship environments were associated with the probability of data 
sharing.  In particular, authors publishing in an open access journal, or with a history of 
sharing and reusing shared gene expression microarray data, were most likely to share 
their data, and those studying cancer or human subjects were least likely to share. 
Although the current results should be considered preliminary, it is disheartening 
to discover that datasets of human and cancer studies have particularly low rates of 
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data sharing.  This sort of data is surely some of the most valuable for reuse, to the 
extent that it can help confirm, refute, advance, and train scientists in bench-to-bedside 
translational research. Further research will be required to understand the interplay of 
an investigator’s motivation, opportunity, and ability that result in a low rate of data 
sharing in these studies [50, 190].  We can make some guesses: As is appropriate, 
concerns about privacy of human subjects’ data undoubtedly affect a researcher’s 
willingness and ability (perceived or actual) to share raw study data.   We do not 
presume to recommend a proper balance between privacy and the societal benefit of 
data sharing, but we do feel strongly that researchers should seriously consider the re-
identification risk of their data on a study-by-study basis [191], evaluate the risks and 
benefits across the wide range of stakeholder interests [45], and consider an ethical 
framework to make these difficult decisions [192].  Data-sharing rates could also be low 
for reasons other than privacy.  Cancer researchers may perceive their field as 
particularly competitive, or cancer studies may have relatively strong links to industry–
two attributes previously associated with data withholding [193, 194].  
NIH funding levels are associated with increased prevalence of data sharing, 
though the overall probability of sharing remains low.  Data sharing is infrequent even in 
studies funded by grants clearly covered by the NIH Data Sharing Policy, such as those 
that receive more than one million dollars per year and awarded or renewed since 2006.  
This result is consistent with reports that the NIH Data Sharing Policy is often not taken 
seriously because compliance is not enforced. [50] 
We are intrigued that publishing in an open access journal, previously sharing 
gene expression data, and previously reusing gene expression data were associated 
with data sharing outcomes. The results are consistent with the results of our pilot 
study, in which we found a strong association between “author experience” and data 
sharing rates [195]. More research is required to understand the drivers behind the 
association.  Does the factor represent an attitude towards “openness” by the decision-
making authors?  Does the act of sharing data lower the perceived effort of sharing data 
again?  Does it dispel fears induced by possible negative outcomes from sharing data?  
To what extent does recognizing the value of shared data through data reuse motivate 
an author to share his or her own datasets? 
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People often wonder whether the attitude towards data sharing varies with age.  
Although we were not able to capture author age, we did estimate the number of years 
since first and last authors had published their first paper.  Our analysis suggests that 
first authors with many years in the field are less likely to share data than those with 
fewer years of experience, but no such association for last authors.  More work is 
needed to confirm this finding given the confounding factor of previous data-sharing 
experience. 
Gene expression publications associated with Stanford University have a very 
high level of data sharing.  The true level is actually much higher than that reflected in 
our study: Stanford University hosts a public microarray repository, and many articles 
that did not have a dataset link from GEO or ArrayExpress do mention submission to 
the Stanford Microarray Database.  If one were looking for a community on which to 
model best practices for data sharing adoption, Stanford would be a great place to start. 
Analyzing data sharing through bibliometric and data-mining attributes has 
several advantages: We can look at a very large set of studies and attributes, our 
results are not biased by survey response self-selection or reporting bias, and the 
analysis can be repeated over time with little additional effort. 
However, this approach does suffer its own limitations.  Our filters for identifying 
microarray creation studies do not have perfect precision, so we may have included 
some non-data-creation studies in our analysis.  Because studies that do not create 
data will not have data deposits, their inclusion alters the composition of what we 
consider to be studies that create but do not share data.  Furthermore, our method for 
detecting data deposits overlooks data deposits that are missing PubMed identifiers in 
GEO and ArrayExpress, so our dataset misclassifies some studies that did in fact share 
their data as non-data-sharing.   
We made decisions to facilitate analysis, such as assuming that PubMed 
identifiers were monotonically increasing with publication date and using the current 
journal data-sharing policy as a surrogate for the data-sharing policy in place when 
papers were published.  These decisions may have introduced errors. 
Missing data may have obscured important information.  For example, articles 
published in journals with policies that we did not examine had a lower rate of data 
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sharing than articles published in journals whose “Instructions to Authors” policies we 
did quantify.  It is likely that a more comprehensive analysis of journal data-sharing 
policies would provide additional insight.  Similarly, the data we included on funders was 
limited: We only included funding information on NIH grants.  Inclusion of more funders 
would help us understand the general role of funder policy and funding levels. 
The Author-ity system provides accurate author publication histories: A previous 
evaluation on a different sample found that only 0.5% of publication histories 
erroneously included more than one author, and about 2% of clusters contained a 
partial inventory of an author’s publication history due to splitting a given author across 
multiple clusters [185].  However, because the lumping does not occur randomly, our 
attributes based on author publication histories may have included some bias.  For 
example, the documented tendency of Author-ity to erroneously lump common 
Japanese names[185] may have confounded our author-history variables with author-
ethnicity. 
Previous work [193] found that investigator gender was correlated with data 
withholding.  It is important to look at gender in multivariate analysis, since male 
scientists are more likely than women to have large NIH grants[196].  We found little 
evidence that gender of the first or last author was associated with data sharing, 
although we recognize limitations in our approach to determining gender.  The Baby 
Name Guesser algorithm empirically estimates gender by analyzing popular usage on 
the internet.   Although coverage across names from all ethnicities seems quite good, 
we were less able to determine gender for Asian names.  This may have confounded 
our gender analysis, and our “gender not found” variable might have served as an 
unexpected proxy for author ethnicity.  
In previous work we used h-index and a-index metrics to measure “author 
experience” for both the first and last author (In biomedicine, customarily, the first and 
last authors make the largest contributions to a study and have the most power in 
publication decisions.).  A recent paper [197] suggests that a raw count of number of 
papers and number of citations is functionally equivalent to the h-index and a-index, so 
we used the raw counts in this study for computational simplicity.  Our reliance on 
citations from PubMed Central (to enable scripted data collection) meant that older 
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studies and those published in areas less well represented in PubMed Central were 
characterized by an artificially low citation count. 
We believe our large sample of 11,603 studies captured a fairly diverse and 
representative subset of gene expression microarray studies, though our method of 
obtaining it through full-text query may have introduced a slight bias towards open 
access journals, as we discussed in Chapter 3. 
This study did not consider directed sharing, such as peer-to-peer data exchange 
or sharing within a defined collaboration network, and thus underestimates the amount 
of data sharing in all its forms. 
Furthermore, this study underestimated public sharing of gene expression data 
on the Internet.  It did not recognize data listed in journal supplementary information, on 
lab or personal web sites, in specialized domains, or in institutional repositories 
(including the well-regarded and well-populated Stanford Microarray Database).  Our 
study methods did not acknowledge deposits into the Gene Expression Omnibus or 
ArrayExpress, unless the database entry was accompanied by a citation to the research 
paper, complete with PubMed identifier.  Finally, our study did not find deposits that had 
been submitted to GEO as a series, unless they had been assembled into a DataSet, a 
curation step for which GEO admits a current backlog 
(http://www.ncbi.nlm.nih.gov/geo/info/faq.html). 
Due to these limitations, care should be taken in interpreting the estimated levels 
of absolute data sharing and the data-sharing status of any particular study listed in our 
raw data.  Nonetheless, we believe the aggregate data does support relative trends. 
Finally, in regression studies it is important to remember that associations do not 
imply causation.  It is possible, for example, that receiving a high level of NIH funding 
and deciding to share data are not causally related, but rather result from the exposure 
and excitement inherent in a “hot” subfield of study. 
We plan to continue analyzing this data.  In the spirit of the topic, we have made 
our raw data available online and encourage others to use it and report their findings.  
We hope these analyses will contribute to a deeper understanding of information 
behavior around research data sharing and eventually a culture that embraces the full 
potential of research output. 
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6.0  CONCLUSIONS  
Aims 1, 2, and 3 were successfully completed, as described in the previous chapters.  
Here I summarize my findings, describe my contributions and their impact to date, 
suggest future work, and share some personal reflections. 
6.1 SUMMARY 
The purpose of this project was not to assess all data sharing behavior in biomedical 
research, but rather to explore three aspects of such an evaluation:    
• Aim 1: Does sharing have benefit for those who share?  
• Aim 2: Can sharing and withholding be systematically measured?  
• Aim 3: How often is data shared?  What predicts sharing?  How can we model 
sharing behavior? 
To begin, we analyzed the citation history of 85 clinical trials published between 
1999 and 2003.  Almost half of the trials had shared their microarray data publicly on 
the internet.  Publicly available data was significantly (p=0.006) associated with a 69% 
increase in citations, independently of journal impact factor, date of publication, and 
author country of origin. 
Digging deeper into data sharing patterns required methods for automatically 
identifying data creation and data sharing.  Data creation is usually only communicated 
in a published study’s full-text article.  Because full text is increasingly queryable 
through portals such as PubMed Central, Highwire Press, and Google Scholar, we 
proposed a method to derive full-text queries from analysis of the open access 
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literature.   The derived full-text query found 56% of data-creation studies in our gold 
standard, with 90% precision.  Next, we established that searching the two 
predominant, public, centralized gene expression microarray databases for biomedical 
literature PubMed identifiers retrieved 77% of associated publicly-accessible datasets. 
We used these methods to identify 11603 publications that created gene 
expression microarray data and estimated that the authors of at least 25% of these 
publications deposited their data in the predominant public databases.  We collected a 
wide set of variables about these studies and derived 15 factors that describe their 
authorship, funding, institution, publication, and domain environments.  Most factors 
were associated with the prevalence of data sharing.  In second-order analysis, authors 
with a history of sharing and reusing shared gene expression microarray data were 
most likely to share their data, and those studying human subjects and cancer were 
least likely to share. 
6.2 CONTRIBUTIONS, IMPLICATIONS, AND FUTURE WORK 
The goal of this project has been accomplished: useful evidence on data sharing 
patterns has been collected through methods that can be applied broadly, repeatably, 
and cost-effectively.  In this section, I summarize the contributions of this project, 
reactions to the portions that have already been published, suggest a few paths to 
confirm the preliminary results and extend the analysis, and speculate about 
implications of the results should they be confirmed. 
6.2.1 Contributions 
This research work has made several contributions in the form of papers and 
associated datasets.  Several of these have been met with a warm reaction, suggesting 
they have made a valuable contribution to ongoing dialog about scientific data sharing: 
• an assessment of citation benefits of data sharing, published in PLoS ONE  
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o Peter Suber, in Open Access News:  “Many studies have shown a correlation 
between OA articles and citation impact.  I believe this is the first study to 
document a similar correlation between OA data and citation impact.” 
o viewed over 13000 times at PLoS ONE 
o 45 citations from items in Google Scholar, including citations from research 
articles, books, and editorials 
• an award-winning proposal (Thomson-Reuters Dissertation Proposal Scholarship for 
2009), openly available online  
o used as a case-study in a PhD-level course at the School of Information 
Studies, McGill University 
• a generalizable approach for developing practical full-text queries for use in 
established academic literature portals, to be submitted for publication 
o in use by a colleague at the National Core for Neuroethics at the University of 
British Columbia 
• an evaluation of the precision, recall, and bias of using PubMed identifiers to find 
publicly available gene expression microarray datasets, accepted for publication 
• an estimate of the prevalence and patterns of gene expression microarray dataset 
sharing and preliminary models of data sharing behavior, to be submitted for 
publication 
• a publicly available dataset associating microarray study publications with data 
sharing status 
• open source Python data collection code and R-project statistical analyses 
6.2.2 Findings 
6.2.2.1 Data sharing is associated with an increased citation rate 
 
Based on 85 cancer clinical trials, we found that publications that made their datasets 
publicly available received 69% more citations than similar publications that did not 
share their data.  Several editorials have cited this evidence when debuting stricter data 
  82
sharing policies, suggesting this finding has been helpful for those trying to promote 
data sharing. 
Before an estimate of the association between data sharing and citation rate can 
have profound implications, however, the estimates need to be confirmed.  Ideally it 
would be confirmed with a larger dataset, more covariates, and different methods 
across several domains and datatypes.  As a first step towards this ambitious goal, I 
plan to use the dataset and covariates collected in this project to investigate the 
association between the data sharing choices and citation rates of the 11603 gene 
expression microarray data-creation studies.  Future work will be needed to adapt the 
automated retrieval methods for use outside biomedicine and gene expression 
microarray data. 
I hypothesize that the association between data sharing and citation rate will be 
confirmed, though I suspect the citation benefit will be smaller than the initial estimate of 
69%.  My guess is that cancer clinical trial data might be reused more than datasets of 
non-human organisms, since bioinformaticians may wish to demonstrate their novel 
tools and methods are applicable to translational research.  I also expect, given the 
current reuse patterns for gene expression microarray data, that as the number of gene 
expression microarray datasets continues to increase over time, any given dataset is 
reused less often.  Furthermore, the initial estimate calculation did not include 
potentially important covariates for predicting citation rate, such as level of NIH funding 
– including these variables may decrease the estimated association between data 
sharing and citation rate. 
I also hypothesize that there are domains and datatypes for which there is no 
citation benefit for sharing data.  In some areas, the cultural norm is to cite an accession 
number rather than the originating paper.  In others, typical reuse involves a very broad 
analysis across all data items in the database:  it is impossible to cite all associated 
papers. 
It is important to note that we do not understand how motivating a citation benefit 
of a given size would be to individual authors.  Furthermore, an estimate of citation 
benefit is just one aspect of potential benefits to individual investigators for sharing data.  
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To present a complete picture, this finding should be integrated with other individual 
benefits, individual costs, societal benefits, and societal costs. 
6.2.2.2 Data creation studies can be identified through full-text queries 
We described and evaluated a method to identify articles that create gene expression 
datasets using open access literature full text as training data and full-text portals as an 
execution environment.   
How useful will this method be, outside of this study?  Identifying data creation 
studies could be useful for investigators looking for data to reuse, for those monitoring 
the adoption of various research methods, and for extracting evidence types for 
biocurators.   
The most important implication of this work, however, is in the general process 
we used. Most research in automated retrieval presupposes that the target literature 
can be downloaded and preprocessed prior to query. Unfortunately, this is not a 
practical or maintainable option for most users due to licensing restrictions, website 
terms of use, and sheer volume.  Scientific article full text is increasingly queryable 
through online portals such as PubMed Central, Highwire Press, Scirus, and Google 
Scholar.  Recognizing that these full-text portals can be used for broad systematic 
retrieval of the biomedical literature based on words and phrases in article full text, 
particularly when queries are developed, refined, and evaluated by applying machine 
learning techniques to open access articles, potentially opens up large areas of 
research and application.   
Further research could increase the impact of this approach.  A review is needed 
to describe the scope and breadth of full-text proxy engines.  The methods presented 
here could easily be offered to the general public as an openly-available web service.  
Derived queries could be improved through application of more advanced text mining 
techniques.  Finally, the methods will have to be refined for domains without well-
organized portals like PubMed Central and Highwire Press. 
  84
6.2.2.3 Datasets can be identified by their PubMed identifiers 
We described and evaluated a method to identify articles that shared gene expression 
microarray datasets in centralized repositories, using PubMed identifiers.  The method 
is not novel, but knowing the recall and bias may encourage adoption of this method by 
others.  We hope to combine this method and others like it in a web service to help 
researchers find datasets for reuse. 
 Unfortunately, this method is difficult to apply to datatypes without centralized 
databases and to domains not covered by MEDLINE.  Future research is needed to 
determine mechanisms for assessing dataset quality. 
6.2.2.4 Many attributes are correlated with data sharing behaviour 
We collected a large dataset and found that many attributes were correlated with data 
sharing behaviour, particularly a history of sharing and reusing shared gene expression 
microarray data and a focus on human subjects and cancer.  These results are 
preliminary:  Confirmation is needed before any of the associations inform policy or 
decisions. 
The immediate implications of this study are those of a proof of concept and 
published dataset:  many new avenues of research.  Structural equation modeling can 
be used to explore causality within the variables.  The environmental factors can be 
further examined and perhaps applied in new contexts.  A deeper look into journal and 
funder policies could be used to explore the direct impacts that their policies have on 
data sharing rates.  The dataset, perhaps supplemented with semi-structured 
interviews, could be used to understand the relationship between capabilities and 
inclinations for the data producing investigators.  
6.2.3 The next frontier 
This study has focused on data sharing.  I plan to turn, next, to the study of data reuse.  
Who reuses data?  When?  Why?  Who doesn’t?  Which datasets are most likely to be 
reused?  How many datasets could be reused but aren’t?  Why aren’t they?  What can 
we do about it?  What should we do about it? 
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6.3 CODE AND DATA AVAILABILITY 
The code and data behind this project are available at http://www.researchremix.org. 
6.4 HOPE 
I hope this research project will contribute to a deeper understanding of data sharing 
behavior and eventually more effective dissemination of research output.  More 
generally, I hope this work facilitates and inspires an increased focus on using research 
methods to study and inform the practice of research.  We owe it to ourselves as 
scientists, as tax-payers, and as patients to pursue biomedical research as effectively 
as possible.  It is only by questioning our assumptions, considering alternatives, and 
evaluating our choices and results that we can choose methods and practices are most 
effective for achieving our desired outcomes. 
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APPENDIX 
UNIVARIATE SHARING PATTERNS ON ORIGINAL VARIABLES 
The appendix includes a 5-part figure (divided at page breaks) illustrating the 
association between the probability that a study shares its gene expression microarray 
dataset and each of our independent variables that describe the study environment. 
Overall prevalence of data sharing was 25%.  The frequency of data sharing is 
shown for each quartile for continuous variables.  Horizontal lines illustrate 95% 
confidence intervals of the data sharing frequencies. 
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Figure 14: Association between shared data and original independent variables 
The frequency of data sharing is shown for each quartile for continuous variables.  
Horizontal lines illustrate 95% confidence intervals of the data sharing proportions. 
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Figure 14 (continued) 
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Figure 14 (continued) 
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Figure 14 (continued) 
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Figure 14 (continued) 
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